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The pattern of mucosal blood flow in normal human stomachs, and benign 
gastric ulcers was assesed with laser Doppler flowmetry and the relationship 
between a single determination of ulcer blood flow and the systemic level of 
growth factors was investigated. 
A significant ascending gradient in mucosal blood flow from the antrum to 
fundus was demonstrated. Different levels of cellular activity in the regions of 
the stomach may explain this gradient. In the gastric ulcers that healed on 
standard medical therapy mucosal blood flow was significantly increased in 
comparison to normal stomachs. In the ulcers that were refractory to standard 
medical therapy mucosal blood flow was significantly lower than in normal 
stomachs and healing ulcers. Higher systemic levels of the growth factor 
bFGF were demonstrated in healing ulcers compared to non-healing ulcers. 
Gastric mucosal blood flow can increase in response to the increased 
metabolic demands of healing, however impairment of this response may be 
an important factor preventing healing of benign gastric ulcers. It would 
appear that non-healing of gastric ulcers can be predicted at initial diagnosis 




1.1 THE PATHOGENESIS OF BENIGN GASTRIC ULCERATION 
1.1.1 Early descriptions of gastric ulceration 
Gastric ulceration was known to the Ancients. Diocles (350-325 BC) , Galen (131-
201 AD) and Palus Aegineta (625-690 AD) each described gastric ulceration and 
the complications of haematemesis and melaena. 1 Marcelius Donatus of Mantua 
described gastric ulcers at necropsy, around 1586.2 Matthew Baillie3 of London 
published "The morbid anatomy of some of the most important parts of the 
human body" in 1793. This is regarded as the first accurate description of the 
pathological appearance and the symptomatology of gastric ulceration. The great 
French clinician Jean Cruveilhier 4 made the clear distinction between benign and 
malignant gastric ulceration. His contribution was highly regarded in his native 
land. With true Gallic "e/an" benign gastric ulceration was referred to in France as 
"the ulcer of Cruveilhier" for many decades following his death. 
However, it was the Germans who dominated surgery in the 19th Century, and 
the surgical treatment of benign gastric ulceration was no exception. Rydygier, a 
Prussian , performed the first successful partial gastrectomy for a benign gastric 
ulcer in 1881.5 His 30-year-old patient was discharged from hospital on the 13th 
post-operative day. The editor's footnote at the end of Rydiger's report of this first 
gastrectomy for a benign gastric ulcer read "Let us hope also the last". Rydiger 
also proposed operating for life threatening haemorrhage from a gastric ulcer. 
2 
Rydiger never achieved the fame that was his due, probably because the honour 
of doing the first successful gastrectomy had gone to Christian Albert Theodor 
Billroth, for malignant disease, earlier in 1881. Although gastric ulceration had 
been known and described for a long time its aetiology and pathogenesis 
remained unclear. 
1.1.2 Historical concepts of gastric ulcer pathogenesis 
The first scientific theories about the pathogenesis of benign gastric ulceration 
arose in the mid-twentieth century. Daintree Johnson (1910-1980) made a 
seminal contribution to the understanding of gastric ulceration and its 
pathogenesis. He stated in 1957, "Every ulcer and no less a peptic one, may be 
considered as the outcome of a conflict between attack and defence, and 
sometimes the violence of the former and sometimes the poverty of the latter, will 
be the paramount factor in pathogenesis". 6 
The realisation that gastric ulceration occurs in patients who are not acid hyper-
secretors led Johnson in 1957 to classify gastric ulcers into three groupS.6 This 
classification was based on the presumed aetiology of the ulcers and was 
believed to have implications for the surgical management of these ulcers. 
A type I ulcer was confined to the lesser curvature without any pathology in the 
duodenum, pylorus or pre-pyloric region. Type I ulcers were usually associated 
with a normal or hypo-secretory acid state. This implied that these ulcers should 
be treated by resectional surgery without vagotomy. Type II gastric ulcers were 
gastric ulcers associated with duodenal ulcers. Type III ulcers were pre-pyloric in 
3 
location. Type II and type III ulcers were associated with acid hyper-secretion, 
and were felt to behave like duodenal ulcers. This implied that they should be 
managed surgically by acid reducing operations such as vagotomy rather than by 
resection. However, it has been shown that the incidence of recurrent ulceration 
is 20% higher in pre-pyloric ulcers treated by a truncal or highly selective 
vagotomy than in duodenal ulcers treated with the same operations.
7
,8 
Nevertheless, Johnson's sound observational data laid the basis for subsequent 
investigators. 
In 1959 Marks,9 proposed an opposing view when he concluded that gastric 
ulceration and duodenal ulceration had a similar aetiology. Marks stated, "It is 
probable that in their pathogenesis pre-pyloric and other gastric ulcers do not 
differ from gastric ulcers associated with duodenal ulcers: the same conflict of 
acid-pepsin aggression versus mucosal defence applies to all." His conclusion 
was based on his observations of Maximum Acid Output (MAO) and Maximum 
Histamine Response (MHR) in 33 gastric ulcer patients. 
In pre-pyloric ulcers MAO and MHR were similar to or slightly higher than normal 
controls. In combined gastric and duodenal ulcers the MAO was slightly higher 
than normal and slightly lower than in uncomplicated duodenal ulcers. In isolated 
gastric ulcers MAO and MHR depended on the duration of symptoms. In long 
standing ulcers acid output was low whilst in acute ulcers acid output was high. 
Marks concluded that the reduction in acid secretion was a consequence of 
gastric ulceration. He felt that peptic (gastric or duodenal) ulceration occurred in 
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normal mucosa exposed to high acid-pepsin secretion or in mucosa abnormally 
susceptible to injury even in the face of diminished acid pepsin secretion. 
Du Plessis 10 in 1965 emphasised the role of refluxing duodenal contents in gastric 
ulcer pathogenesis. He identified severe chronic gastritis extending from the 
pylorus for a variable distance proximally in 61 of 75 stomachs, which had been 
resected for benign gastric ulceration. The gastric ulcers were all situated in the 
area of atrophic gastritis. Du Plessis aspirated resting stomach juice from 
patients with gastric ulcers, dyspepsia, duodenal ulcers and normal stomachs. 
The aspirates in the patients with gastric ulcers had high concentrations of bile-
acid conjugates. He concluded that gastric ulceration is preceded by chronic 
gastritis secondary to refluxing of duodenal contents. He postulated that refluxing 
alkaline duodenal contents interfered with the protective layer of mucous and 
allowed acid and pepsin to come into contact with the mucosa. This promoted 
ulceration. 
The unifying principle behind these concepts is that benign gastric ulceration 
arises from an imbalance between aggressive luminal factors and the integrity of 
the mucosal barrier. The role of the mucosal barrier is pivotal to mucosal defence. 
Our current understanding of the pathogenesis of benign gastric ulceration 
emphasises this concept. 
1.1.3 Current concepts in gastric ulcer pathogenesis 
In the early 1980's Marshall revolutionised the world's understanding of the 
pathogenesis of peptic ulcer disease. 11 -13 Marshall isolated a spiral urease-
5 
producing organism, in the interface between the epithelial cells of the gastric 
mucosa and the overlying mucous layer, which was called Campylobacter pylori. 
Campylobacter pylori, was subsequently renamed Helicobacter pylori (H. pylon), 
and became the subject of intense investigation. 
A strong causal relationship between H. pylori infection and upper gastrointestinal 
disease has been documented. The overwhelming majority of duodenal ulcers 
are H. pylori positive. 14-18 Furthermore successful eradication of H. pylori 
infection markedly reduces the rate of duodenal ulcer recurrence and offers a 
permanent cure. However in gastric ulceration the association with H. pylori is 
less striking. Only 70 to 90% of patients with benign gastric ulcers are infected 
with H. pylori. 19 Borody et al. 20 reported a series of 115 patients with gastric 
ulcers. Only 71 (62%) were H. pylori positive, and 44 (38%), were H. pylori 
negative. 
Other factors, such as cigarette smoking and ingestion of Non-Steroidal 
Anti-Inflammatory Drugs (NSAID's), are implicated in the pathogenesis of benign 
gastric ulceration.21 - 23 However in the study of Borody et al., 13 (30%) of the H. 
pylori negative group had no identifiable cause of a gastric ulcer.2o This may 
merely represent the inability to identify H. pylori due to poor techniques, or 
suppression of H. pylori rather than eradication, secondary to the use of 
inappropriate antibiotics. 
The re lationship between H. pylori and NSAID use remains unclear. There is 
evidence that H. pylori associated and NSAID associated gastric ulcers are 
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distinct pathological entities. Laine points out that there does not appear to be a 
difference between NSAID users and non-users as far as the incidence of H. 
pylori infection is concerned. 19 NSAID's cause sub-epithelial haemorrhage and 
erosions but do not cause the increase in inflammatory infiltrate in the gastric 
mucosa which is typical of H. pylori associated gastritis. H. pylori positive NSAID 
users with gastric ulcers have more inflammation than H. pylori negative NSAID 
users with gastric ulcers. Furthermore patients with NSAID associated gastric 
ulcers tend to have a lower prevalence of H. pylori and less gastritis than non-
NSAID users. However, a patient who is H. pylori positive and who uses NSAID's, 
is at higher risk of developing a gastric ulcer due to the synergistic effect of two 
noxious stimuli on the gastric mucosa. Laine 19 feels that NSAID associated ulcers 
represent a subset of gastric ulceration, which do not require H. pylori to develop. 
To paraphrase Johnson,6 gastric ulcers are increasingly seen as local areas of 
mucosa in which the effects of noxious luminal stimuli (acid, pepsin) have 
overcome the ability of the gastric mucosa to maintain mucosal integrity. 
Ulceration occurs secondary to impaired mucosal resistance. The causes of this 
impaired mucosal defence are numerous, but include H. pylori infection, cigarette 
smoke and NSAID use. The common pathway of the impaired mucosal defence 
is unclear. Reduced mucosal blood flow may be an important part of the final 
common pathway. 
1.1.4 Mucosal blood flow and mucosal ulceration 
Mucosal defence and ulceration is a dynamic process. Mucosal blood flow plays 
an important role in maintaining mucosal integrity through the removal of back 
7 
diffusing Hydrogen ions and in providing adequate nutrients to the mucosa. 
Alterations in mucosal blood flow are important in the breakdown of this fine 
balance between defence and ulceration.24 This is the situation in acute mucosal 
injury.25 The role of mucosal blood flow in chronic ulceration is less clearly defined 
but appears to be equally important. 
Mucosal blood flow also plays a central role in mucosal healing.
24 
An adequate 
supply of oxygen and nutrients is essential for the high energy demanding 
processes involved in mucosal healing. These include in-growth of epithelial cells 
and angiogenesis from intact vessels surrounding the ulcer and removal of 
metabolic waste products. 
1.1.5 Growth Factors and mucosal blood flow in gastric ulcer healing. 
Gastric ulcers share many features with wounds in other sites. Healing requires 
epithelial cell migration, epithelial cell proliferation and the growth of granulation 
tissue.26 Cell proliferation and migration are triggered and regulated by growth 
factors and cytokines through their action on specific receptors. Growth factors 
and cytokines are both extra-cellular signalling peptides. Cytokines are 
considered to be local mediators in cell to cell communication whereas growth 
factors were originally defined on the basis of their stimulating cell growth and cell 
division. Several growth factors have been shown to exhibit gastro-protective, 
mitogenic and angiogenic activities and to accelerate gastric healing. Healing is 
initiated and controlled by secretion of growth factors at the ulcer edge. These 
peptide growth factors modulate cell proliferation by acting as ligands at specific 
trans-membrane receptors. The role of many growth factors and cytokines is still 
8 




Different ulcer types (skin, gastric and intestinal ulcers) demonstrate similar 
mechanisms of ulcer healing.26 Subsequent to ulceration, cells adjacent to the 
crater rapidly de-differentiate in response to growth factors. A novel cell line 
grows from the base of existing crypts. This cell line contains Epidermal Growth 
Factor (EGF), which is a potent stimulator of cell proliferation.3D Parallel to 
secretion of growth factors, inflammatory infiltration occurs close to the necrotic 
tissue and the ulcer crater. Granulation tissue develops below the ulcer base as 
part of the repair process and may prevent perforation. Epithelial cells are 
stimulated by growth factors and migrate over the ulcer crater. 
During the initial acute phase of ulceration and healing, inflammatory cells are 
seen prominently around the ulcer circumference. Later fibroblasts and micro-
vessels replace these inflammatory cells. Angiogenesis (in-growth ·of new 
vessels) supports healing by improving nutrient and oxygen delivery. After re-
epithelialisation all the layers of the gastric wall including the mucosa, muscularis, 
submucosa, muscularis propria and serosa are reconstructed.26 
Peptide growth factors play an important role in promoting ulcer healing. Their 
function is intimately related to mucosal blood flow, and administration of 
angiogenic promoting factors to rats has been shown to promote ulcer healing.26, 
31 Angiogenesis ensures an adequate nutrient supply to support the high energy 
demanding process of mucosal healing. Growth factors modulate cellular growth 
and angiogenesis by altering genetic transcription.32-35 Adequate mucosal blood 
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flow allows efficient buffering of back diffusing Hydrogen ions. The three growth 
factors which have been most studied, in association with gastrointestinal 
pathology, are basic Fibroblast Growth Factor (bFGF), EGF and Transforming 
Growth Factor (TGF). The following section presents an overview of these three 
growth factors. 
1.1.6 Fibroblast Growth Factor 
FGF is a potent angiogenic factor, which is expressed in most cells of the body. 
Initially only two forms of FGF were known, acidic (FGF1) and basic (FGF2). In 
1991 the New York Academy of Science divided the FGF family into seven 
members?6 Subsequently the number of FGF sub-groups has increased to nine. 
Basic and acidic FGF are the best characterised members of the family. b-FGF is 
an 18 kDa polypeptide with a high affinity for heparin and heparin sulphate 
proteoglycans. b-FGF is stored within the extra-cellular matrix, and is a direct 
mitogen for vascular endothelial cells. The FGF receptors are a subgroup of the 
tyrosine kinase family and display a remarkable degree of cross affinity for the 
different FGF subtypes. 
1.1.7 Transforming Growth Factor 
TGF was first isolated from culture medium conditioned by Rous sarcoma virus 
transformed fibroblasts. The addition of the, at the time, still un-named growth 
factor transformed normal fibroblasts into malignant fibroblasts. The peptide was 
therefore named Transforming Growth Factor. There are two superfamilies, TGF-
a and TGF-~. The members of the TGF-~ superfamily have a variable pro-domain 
and a highly conserved 110-114 amino acid residue mature segment. This 
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segment contains seven cysteine residues and forms the cysteine knot. TGF-~1 
is one of the isoforms of the TGF-~ superfamily. TGF-~1 is secreted in a latent 
form and is converted to the active form at the cell surface and in the extracellular 
matrix. TGF shares about 35% amino acid sequence homology with EGF and 
binds to the same receptors as EGF. TGF inhibits gastric acid secretion and is 
angiogenic. Expression of m-RNA for TGF has been found in the gastric mucosa 
of guinea pigs, rats, dogs and humans.37 
1.1.8 Epidermal Growth Factor 
EGF was first isolated from the rat submandibular gland. EGF is formed as a pro-
molecule of 1217 amino acid residues and includes six cysteine residues that 
form three disulphide bonds.3D The EGF receptor (EGFR) is a tyrosine specific 
"single pass" transmembrane protein of around 1200 amino acid residues. The 
EGFR has a large glycosylated extra-cellular domain that binds EGF. This leads 
to the activation of the intracellular tyrosine domain. This transfers phosphate 
from ATP on selected tyrosine side chains. After binding, down regulation of 
receptors occurs with lysosomal degradation of EGFR. EGFR 's are not specific 
for EGF and may also serve as receptors for TGF-a. 
EGF is known to stimulate DNA synthesis in the gastric mucosa of rodents.27,38 
Tepperman and Soper,39 administered a bolus of the nitric oxide synthase 
inhibitor, NG nitro-L-arginine methyl ester, to rats which had been pre-treated with 
intra-luminal HCL. This resulted in a significant increase in the area of mucosal 
haemorrhagic damage, and a significant reduction in mucosal blood flow. The 
extent of the mucosal damage was greater in rats, which had been 
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sialoadenectomised. Intravenous administration of EGF however limited the 
extent of the mucosal damage and prevented the decrease in mucosal blood flow 
in the sialoadenectomised rats. 
1.2 THERAPY FOR GASTRIC ULCERS 
1.2.1 Acid suppression and gastric ulcer therapy 
Gastric ulcer therapy has evolved and improved from the 1970's. Initially anti-
ulcer therapy focused on promoting healing by reducing acid load, hence 
removing the noxious stimulus and allowing mucosal healing. Acid reducing drugs 
progressed from the development of the histamine receptor antagonists, to the 
Proton Pump Inhibitors (PPI). However, ulcer healing can be induced by drugs 
that do not alter gastric acidity, and the discovery of H. pylori has opened up new 
forms of therapy. Acid suppression remains an important part of the therapy of 
benign gastric ulcers. 
In 1981 Wright et al.,40 documented a healing rate of 53% for gastric ulcers on 
medical therapy. However surgical therapy was eventually required in 56% of the 
group. The medical therapy of the time was not very efficacious. Wright et al.41 
subsequently compared the efficacy of the histamine receptor antagonists, 
ranitidine and cimetidine in ulcer healing in 72 patients with benign gastric ulcers. 
The one-month healing rate was 47% for the ranitidine group and 52% for the 
cimetidine group. Treatment was continued for a further four weeks in the non-
healing ulcers. The final healing rate was improved to 77% in the ranitidine group 
and 76% in the cimetidine group. There was a trend for larger ulcers to take 
longer than four weeks to heal.41 Athough these results were an improvement, a 
l2 
significant number of gastric ulcers still remained refractory to treatment with acid 
suppression by histamine receptor antagonists. 
The place of anti-secretory drugs in medical management of benign gastric 
ulceration is well established.42 However, gastric ulcers are not always 
associated with hyper-acidic states and therefore there is less rationale for the 
use of these agents in gastric ulceration in comparison to duodenal ulceration. 
Howden et al.43 in a meta-analysis of 56 clinical trials of anti-secretory drugs in 
benign gastric ulceration, showed that conventional dosing regimens consistently 
heal about 80% of gastric ulcers by eight weeks. He showed that extending the 
period of treatment from eight weeks to twelve weeks resulted in almost 100% 
healing rates. Furthermore he could show no association between healing rates 
and acid suppression. This was in marked contrast to the situation in duodenal 
ulceration where there is a marked correlation between the degree of acid 
suppression and the rate of ulcer healing.42 
The development of the PPls enabled a much greater therapeutic level of acid 
suppression to be achieved than that achieved by the anti-histamines. However 
healing rates are still short of the desired 100% cure rate. In 1998 Yeomans44 
reported an 83% cure rate for NSAID induced gastric ulcers on Omeprazole at 
20mg daily, in comparison with a rate of 93% for duodenal ulcers on identical 
treatment. 
Gastric ulcers take longer to heal than duodenal ulcers, when acid suppression is 
the sole modality of treatment. Despite a marked improvement in the healing 
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rates of gastric ulcers over the last two decades, refractory ulceration remains a 
problem. Today, elective gastric surgery for benign disease is rare. (Rydiger's 
editor would be pleased to know). However, Soll45 stated in 1996, "The 
therapeutic response of gastric ulcers is somewhat slower than for duodenal 
ulcers, in part because gastric ulcers are generally larger than duodenal ulcers". 
He recommended that large gastric ulcers should only be considered refractory if 
they have not healed after twelve weeks of therapy. Gastric ulcers tend to be 
more refractory than duodenal ulcers. Refractory gastric ulceration remains a 
clinical problem. The reasons for non-healing are multiple and include failure to 
eradicate H. pylori, poor compliance, and persistent smoking and NSAID use. 
1.2.2 Gastric ulcer healing using non-acid suppression therapy 
Sucralfate is effective against acute chemical-induced haemorrhagic mucosal 
lesions and accelerates the healing of chronic gastric ulcers without decreasing 
gastric acidity.46-50 The mechanism of action of sucralfate is incompletely 
understood. It has been shown to reduce micro-vascular injury and to maintain 
mucosal blood flow in acute lesions in rats. This allows rapid epithelial restitution. 
In chronic ulcer healing in rats sucralfate has been shown to promote 
angiogenesis.
32 
This may be due to its ability to bind endogenous growth factors 
and prevent degradation of these factors by luminal acid. The effectiveness of 
sucralfate in therapy of gastric ulceration has contributed to a new understanding 
of gastric ulcer pathogenesis and healing, which emphasises the importance of 
the mucosal barrier and mucosal blood flow in gastric ulceration. 
Chen et al.
51 
showed that sucralfate exerted its effect by increasing mucosal 
14 
blood flow. He used an ex-vivo gastric chamber preparation and laser Doppler 
flowmetry to study the effect of sucralfate on gastric mucosal blood flow in rats. 
Gastric mucosal blood flow was measured in rats following topical application of 
absolute ethanol alone or after pre-treatment with sucralfate. The total area of 
haemorrhagic mucosal lesions was measured to document the degree of 
mucosal damage. Pre-treatment with sucralfate significantly reduced the extent 
of mucosal damage. Mucosal blood flow was significantly reduced subsequent to 
ethanol application. This fall in blood flow was attenuated by pre-treatment with 
sucralfate in both fasted and fed rats. Graded doses of sucralfate resulted in an 
increase in gastric mucosal blood flow in a dose dependent manner. Chen 
concluded that sucralfate increases gastric mucosal blood flow in rats and 
attenuates the reduction in blood flow induced by ethanol. 
Preservation and enhancement of gastric mucosal blood flow seem to be the 
mechanism by which sucralfate promotes healing of gastric ulceration. It would 
seem that sucralfate interacts with growth peptides and hence promotes mucosal 
healing. Folkman et al.52 extended this concept to produce a hypothetical model 
of ulcer formation and healing which also explained the healing effect of 
sucralfate. FGF is continuously produced by the gastric and duodenal mucosa. 
However its production is balanced by continuous degradation of peptide by 
gastric acid. The traditional hypothesis is that acid directly causes the ulcer. 
Folkman et al. however postulated that mucosal ulceration occurs only if FGF is 
broken down.52 He proposed that sucralfate binds to endogenous FGF and 
prevents its breakdown so facilitating ulcer healing. This is achieved without 
altering acid concentration. 
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1.2.3 Growth factors and gastric ulcer therapy 
Experimentally, peptide growth factors have been shown to enhance gastric ulcer 
healing. Folkman et al.52 showed that an acid stable form of bFGF could be 
administered orally to rats with duodenal ulcers. The peptide induced a nine-fold 
increase in angiogenesis in the ulcer bed and accelerated ulcer healing more 
potently than the acid reducing histamine receptor antagonists. Therapeutic 
intervention in gastric ulceration has mostly been directed against aggressive 
factors. With the discovery of the potent healing capacity of growth factors, direct 
treatment of ulcers may be possible regardless of acid and pepsin secretion. 
Growth factor therapy is still experimental.34 However its efficacy provides insight 
into the healing process in gastric ulceration. Ulcers will heal if the noxious stimuli 
are removed, by acid suppression and H. pylori eradication. However, if mucosal 
blood flow is enhanced, healing will occur even in the presence of these noxious 
factors. This illustrates in practical therapeutic terms the inter-relationship 
between mucosal blood flow, injury and healing. 
1.2.4 Helicobacter pylori therapy 
Since 1983 H. pylori has been recognised as a causal factor in gastric ulceration. 
The American College of Gastroenterology has recommended that all patients 
with peptic ulceration and proven H. pylori infection should be treated with 
eradication therapy.14,15,45,53 Decisions about eradication therapy should take 
account of previous antibiotic exposure and local resistance patterns. A bismuth-
metronidazole-tetracycline combination plus proton pump inhibitors or 
clarithromycin and either metronidazole or amoxicillin plus PPI will achieve a 90% 
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cure rate probably within one week of therapy.45 Regardless of H. pylori status, 
conventional therapy based on the principle of reducing the noxious stimuli of 
. h I' 53 mucosal ulceration, is necessary to relieve symptoms and to promote ea Ing. 
1.3 TECHNIQUES OF MEASURING GASTRIC MUCOSAL BLOOD FLOW 
Much effort has been expended to develop a satisfactory technique of measuring 
gastric mucosal blood flow in humans. In order for a technique to be widely 
applicable it must be safe, simple to use, reproducible and reliable. An overview 
of the most widely available techniques is given in the following section. 
1.3.1 Microsphere distribution technique 
Microspheres injected into the left ventricle of the heart will be evenly distributed 
in the blood stream. These microspheres will be distributed to the organs of the 
body, in direct proportion to the regional perfusion of each organ.25,54 Radio-
labelled or coloured microspheres of the appropriate diameter (15 /lm) will lodge 
in the lamina propria of the gastric mucosa below the gland bases. Here they can 
be measured and blood flow can be derived from these measurements. 
Microsphere clearance permits accurate flow measurements of the entire gastric 
wall as well as the mucosa. It also allows measurement of flow to different 
regions of the gastric mucosa and is independent of the secretory state of the 
stomach. There are a number of restraints on the widespread application of the 
microsphere distribution technique. A limited number of measurements may be 
made at each sitting. Radioactive material is used and the stomach must be 
removed prior to blood flow measurement. This restricts its application to animals 
and makes it costly and time-consuming. 
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1.3.2 Clearance techniques 
In 1966 Jacobson et al.55.56 developed the aminopyrine clearance technique for 
the determination of gastric mucosal blood flow. The method is based on the 
permeability of lipid membranes to the undissociated but not to the dissociated 
form of compounds. At the pH of plasma a weak base such as aminopyrine 
(pKA=5) is present in the undissociated state and readily traverses the gastric 
mucosa. At the pH of gastric juice the weak base ionises and aminopyrine is 
trapped in the stomach lumen. Aminopyrine is cleared from the blood on a single 
pass through the gastric mucosa. Thus the clearance of aminopyrine into the 
gastric juice is a direct measure of gastric mucosal blood flow. However, the large 
doses of aminopyrine required meant that the technique was not suitable for use 
in humans until Tague and Jacobson in 1976 reported on the use of [14C] 
aminopyrine to measure gastric mucosal blood flow in dogS.57 Only a trace 
amount of this compound was needed to make the measurement. This allowed 
Guth et al. to apply this technique to humans in 1978.58 They showed that 
pentagastrin stimulation increased gastric mucosal blood flow. Archibald et al.59 
showed that aminopyrine clearance is different in the secreting and non-secreting 
stomach. They correlated microsphere measured flow with aminopyrine 
clearance during intravenous infusion of histamine and isoproterenol. In the 
histamine group the aminopyrine clearance averaged 83% of microsphere 
determined flow. In the isoproterenol group the correlation between aminopyrine 
clearance and microsphere clearance was very poor. This implies that 
aminopyrine clearance underestimates mucosal blood flow in the non-secreting 
stomach. 
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There are other limitations with the aminopyrine clearance technique. 
Aminopyrine clearance represents overall mucosal blood flow and cannot assess 
regional differences. Furthermore, the technique requires prolonged naso-gastric 
intubation, aspiration of gastric secretions and collection of systemic blood 
samples which makes it labour intensive and uncomfortable for the subjects. 
1.3.3 Hydrogen gas clearance 
This technique, first reported by Murakami et al.,60 is based on the dissociation of 
molecular Hydrogen at the surface of a platinum probe into Hydrogen ions and 
electrons. The rate of removal of Hydrogen from perfused tissue is determined by 
the rate of blood flow. The Hydrogen gas is inhaled. A platinum electrode is 
placed on the mucosal surface. This generates a current (due to oxidation of 
Hydrogen), which is proportional to the concentration of Hydrogen in the tissue. 
Hydrogen gas clearance has been validated against microsphere technique. 
Soybel et al. 61 assessed the effects of changes in luminal pH and the secretory 
activity of the gastric mucosa on the accuracy of Hydrogen clearance 
measurements. Hydrogen clearance measurements at different pH levels were 
compared in vitro and in vivo. Furthermore, blood flow measurements by 
hydrogen clearance and radioactive microsphere clearance were compared 
during stimulation of acid secretion by infusion of histamine, and during 
suppression of acid secretion by infusion of cimetidine. They showed that in vitro 
hydrogen washout was relatively constant over a spectrum of pH values, ranging 
from two to eight. For the in vivo experiments they used chambered segments of 
the canine fundus. In these animals Hydrogen clearance was not significantly 
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affected by pH of the luminal solutions either in the resting state or at lower blood 
flows induced during infusion of vasopressin. They demonstrated a close 
correlation between measurements of mucosal blood flow as determined by 
Hydrogen clearance and microsphere clearance under resting conditions. This 
correlation was also demonstrated during intravenous histamine stimulation of 
acid secretion and after suppression of acid secretion by infusion of cimetidine. 
They concluded that the hydrogen clearance technique was an accurate method 
for measuring gastric mucosal blood flow over a range of physiological conditions. 
This technique was the first that was easily adapted for human use. There is no 
limit to the number of measurements that can be made. However, the method is 
incapable of detecting rapid changes in blood flow as it takes on average thirty 
minutes to make a single measurement. 
1.3.4 Laser Doppler flowmetry 
Stern et al.,62 Bonner and Nossal63 , and Bonner et al.64 have described the 
physics of laser Doppler flowmetry. A detailed description of the physics is given 
in Appendix 2. Numerous investigators have reported on the use of laser Doppler 
flowmetry in the gastrointestinal tract of both human and animal subjects. 
1.3.5 The laser Doppler instrument 
The laser Doppler instrument has a laser diode, which generates a wavelength of 
780 nm. This is near the isobestic point of oxyhaemoglobin and 
deoxyhaemoglobin (800 nm). This wavelength is not absorbed by dark tissue and 
so eliminates the effect of changes in blood oxygenation on the Doppler reading. 
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A fibre optic cable delivers the laser beam to the tissue and carries the signal 
back to the photo-detector where the spectrum of frequencies are collected and 
indirectly measured by a process called heterodyning. The output of the photo-
detector is a spectrum of frequencies, which cannot be simply characterised. The 
signal is processed by a filter using the root mean square band-width of the 
power spectrum to compute a single value for flow. 
1.3.6 The validity of laser Doppler flowmetry 
The validity of laser Doppler depends on empirical demonstration that blood flow 
determined by laser Doppler scales linearly with blood flow detected by an 
independent technique. Various authors have validated laser Doppler flowmetry 
against other techniques of measuring mucosal blood flow, and their work is 
discussed in the following section. 
Kvietys et al.65 measured blood flow in the mucosa of the feline jejunum by laser 
Doppler flowmetry and Hydrogen gas clearance. Laser Doppler and Hydrogen 
clearance estimates were compared with measurements of total-wall blood flow 
and mucosal-submucosal blood flow made by the radio-labeled microsphere 
technique. They demonstrated a significant linear correlation between laser 
Doppler flowmetric measurements and total jejunal wall blood flow as measured 
by the microsphere technique. They also demonstrated a significant correlation 
between laser Doppler measurements and mucosal-submucosal blood flow as 
measured by the microsphere technique. The Hydrogen clearance technique 
tended to over-estimate total blood flow of the wall of the jejunum when compared 
to the microsphere clearance technique. They postulated that Hydrogen 
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clearance selectively measured flow in the mucosa. This was felt to be 
surprising, as hydrogen gas should be subject to counter-current exchange within 
the vi lli of the small intestine. The counter-current exchange of hydrogen ions in 
normally perfused feline small bowel could be as high as 95%. Theoretically this 
could lead to an underestimation of mucosal blood flow in the small intestine. 
However, they cautioned that these findings were applicable only to physiological 
conditions of intestinal blood flow (26 to 74 mllmin/100g of tissue). They felt that 
this could limit the use of Hydrogen clearance in situations of impaired blood flow. 
Laser Doppler correlated well with both total jejunal wall blood flow and mucosal-
submucosal flow. 
Kiel et al. 66 used two laser Doppler flowmeters to simultaneously monitor blood 
flow in the mucosa and serosa of chambered canine stomachs. In isolated gastric 
segments vasodilated with isoproterenol, laser Doppler flowmetry demonstrated 
that mucosal and muscularis blood flows were both linearly related to total 
electromagnetic blood flow. 
Feld et al.
67 
compared laser Doppler flowmetry with electromagnetic total blood 
flow measurements in isolated segments of canine small intestinal mucosa. They 
demonstrated good correlation between the methods. Administration of 
vasoactive drugs such as norepinephrine caused a decrease in mucosal 
perfusion as recorded by the two methods. 
Gana et al.
68 
compared focal gastric mucosal blood flow values simultaneously 
obtained by laser Doppler flowmetry and Hydrogen gas clearance. Readings 
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were made at the same point in a chambered segment model of the gastric 
fundus in nine anaesthetised dogs. The gastric mucosal blood flow values 
determined by laser Doppler flowmetry correlated closely with the values 
determined by Hydrogen clearance. 
Ahn et al.69 evaluated the use of laser Doppler flowmetry to measure gastric 
blood flow in cats. In five cats flowmeter signals and venous outflow of the 
stomach were simultaneously recorded. Temporal reproducibility was assessed 
by comparing the variation of the flowmeter signal during a state of constant 
blood flow with the variation in flow measured by a drop-counting technique. This 
was repeated over four recording periods of fifteen minutes each. Spatial 
reproducibility was assessed in a single cat by moving the probe to a point 1 cm 
distant from the original point and repeating the measurements. The flowmeter 
recordings were highly reproducible for both temporal and spatial variation with a 
coefficient of variation varying between 4% and 13%. A significant correlation 
coefficient was obtained between flowmeter signal and venous outflow of the 
stomach. However, during complete occlusion of the coeliac plexus, when no 
venous outflow was detected, the laser Doppler flowmeter still detected a reading, 
which was approximately 30% of the pre-occlusion reading. This was ascribed to 
the heterogeneous vascular supply of the stomach. 
There are limitations to and controversies surrounding the use of laser Doppler. 
The depth of tissue sampled by laser Doppler is unclear. In all tissue light will 
diffuse after passing through 300-600 ~m of tissue. This mean path for light 
diffusion and the spatial separation of the light conducting fibres are the primary 
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determinants of the tissue volume sampled. Thus for 600 11m fibre separation and 
typical tissue, the depth of sampled tissue is about 0.6-1.2 mm. The laser Doppler 
instrument used by Kiel et al. was specifically built by Bonner.66 These authors 
asserted that their instrument had a penetrative depth of 0.5-1.0 mm. However 
the penetrative depth of laser Doppler has been the subject of a great deal of 
investigation, and still remains controversial. Kvietys et al.65 placed a non-
perfused layer of tissue between the laser probe and the perfused mucosal 
surface. The signal was diminished by up to 20%. Occluding the arterial supply 
of the segment of jejunum decreased mucosal blood flow. The laser Doppler 
reading made through the interposed non-perfused segment decreased. On 
reperfusion the laser Doppler reading increased. This implied that their laser 
Doppler flowmeter (Periflux®. Model Pf 1 d Perimed, Stockholm) was capable of 
detecting fluctuations in blood flow through 3 mm of non-perfused tissue. They. 
concluded that laser Doppler flowmetry measured total wall blood flow rather than 
mucosal blood flow. 
Johansson et aJ?o measured blood flow in the mucosa and serosa in 49 patients 
undergoing small bowel resection, in 36 patients undergoing colonic resection 
and in 54 patients undergoing gastric resection. Two different laser Doppler 
flowmeters were used: the PF1 d and PF2 (Periflux®, Perimed, Stockholm, 
Sweden). Recordings of total venous out-flow were made by isolating a segment 
of bowel and cannulating the draining vein. Venous out-flow was collected in a 
graduated glass. Mucosal and serosal flowmeter signals were compared during 
resting conditions, vascular occlusion, and reactive hyperaemia. The magnitude 
of the mucosal and serosal flowmeter signals was comparable throughout the 
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small bowel , large bowel and stomach. Following pentagastrin stimulation a 
significant increase in laser Doppler flowmetric readings was recorded from the 
serosal and mucosal surface of the stomach. There was also a significant 
correlation between total wall blood flow (as measured by total venous outflow) 
and laser Doppler readings. This was similar in the small and large bowel. 
Johansson et a!?O agreed with Kvietys et a/. ,65 that laser Doppler flowmetry had a 
tissue penetration depth of at least 6 mm, and therefore measured whole wall 
perfusion rather than mucosal perfusion. 
Other authors have come to the opposite conclusion. They feel that laser Doppler 
flowmetry measures mucosal rather than total wall flow. Stern et a/.62 showed that 
the insertion of a 1 mm thick non-perfused layer between the probe and the 
mucosa eliminated any signal. They felt this implied that the laser Doppler 
instrument had a penetrative depth of 1 mm. Kiel et al.66 determined the 
penetrative depth of laser Doppler flowmetry by observing reactive hyperaemia 
following arterial occlusion . Reactive hyperaemia was frequently detected by 
laser Doppler in the mucosa, but rarely in the muscularis. Placing a layer of non-
perfused tissue between the probe and the perfused mucosa abolished the 
resting laser Doppler mucosal flow signal and attenuated the recording of peak 
hyperemia by 85%. These findings indicate that laser Doppler flowmetry 
instruments yield linear, superficial measurements of gastric blood flow in either 
mucosa or muscularis rather than total wall blood flow. 
Shepherd and Riedel71 also demonstrated that laser Doppler flowmetry measured 
mucosal rather than total wall blood flow. They recorded laser Doppler flowmetric 
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measurements and total electromagnetic measurements whilst altering the 
perfusion pressure in an isolated vascularised segment of canine small bowel. In 
a second series of experiments they infused either isoproterenol or adenosine 
intra-arterially to vasodilate the preparations. In a third series they occluded the 
supply catheter and used the laser Doppler flowmeter to record the reactive 
hyperaemic response in the mucosa and the muscularis. They showed that after 
60 seconds of arterial occlusion, laser Doppler flowmetry demonstrated a 
hyperaemic response in the mucosa, but not in the muscularis. This was taken as 
evidence that laser Doppler flowmetry measured blood flow in the mucosa and 
not the entire bowel wall. When isoproterenol was infused, the expected 
vasodilatory response was seen first in the mucosa with laser Doppler. The 
mucosal hyperaemia preceded the total increase in bowel wall blood flow as 
detected by the electromagnetic flowmeter. This was taken as further evidence 
that laser Doppler measures mucosal blood flow rather than total bowel wall 
blood flow. Adenosine, which diverts blood from the mucosa, resulted in a 
decrease in mucosal blood flow as measured by laser Doppler. 
Stern et al.,62 Kiel et al.66 and Shepherd and Riedel71 demonstrated that laser 
Doppler flowmetry measures mucosal flow rather than total wall flow. Kvietys et 
al. 65 states that the laser Doppler instrument used by Shepherd and Riedel and 
Kiel et al. was specifically designed for them by Bonner. Details of the 
instrument's components are not given in the paper. However it is apparently 
similar to the instrument used by Stern et al.,62 for which details are given. Their 
instrument used a helium-neon laser with a wavelength of 632.8 nm and a beam 
diameter of 1 mm. The returning light was reflected through a 2 mm aperture 
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placed at the surface of the tissue, which limited stray, and a second 0.5 mm 
aperture 1 m away, which selected out a single coherence area. They feel that 
differences between components such as diameter, separation, and the 
numerical aperture of the optical fibres could account for the difference in depth 
sensitivity between different laser Doppler instruments. These differences must 
be borne in mind when interpreting results obtained using laser Doppler 
flowmetry. 
Laser Doppler has been shown to be accurate under a variety of 
pathophysiological conditions. Casad eva II et al.72 compared laser Doppler 
flowmetry, reflectance spectrophotometry and the Hydrogen gas clearance 
technique in rats under conditions of hypoxia, hyperoxia, acute normovolaemic 
anaemia and pharmacologically induced vasoconstriction. They, showed a good 
correlation between laser Doppler and the other techniques under conditions of 
vasoconstriction, hypoxia and hyperoxia. However under conditions of anaemia 
laser Doppler flowmetry appeared to be limited by the decreased number of red 
blood cells in the field under examination. 
We felt that laser Doppler flowmetry had been sufficiently validated by the above 
authors to be used as a scientific tool. Laser Doppler can easily be used during 
upper endoscopy, making it an attractive tool for experimental and clinical work. 
The measurements add on average five to ten minutes onto the time taken for a 
routine upper endoscopy. They are easy to repeat at a subsequent endoscopy 
and are well tolerated by the patients. Furthermore, laser Doppler allows the 
measurement of gastic mucosal blood flow at multiple sites in the stomach. 
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However the controversies and problems with laser Doppler must be borne ' in 




Mucosal blood flow is dynamic and reflects the functional state of the gastric 
mucosa. Mucosal ulceration is a state in which the fine balance between acid 
bathing the mucosa and mucosal defence has broken down. Mucosal healing is 
an energy dependent process, involving epithelialisation, angiogenesis and 
cellular differentiation, which depends on adequate blood flow for supply of 
energy and nutrients and the removal of metabolic waste products. It is 
postulated that blood flow in the gastric mucosa will vary with pathological 
conditions of the stomach in response to changing metabolic demands. If such 
alterations do occur in relationship to benign gastric ulceration they should be 
detectable with laser Doppler flowmetry. As growth factors are involved in 
controlling the healing process, fluctuations in the systemic levels of growth 




1 . To investigate the blood flow distribution in normal human stomachs by 
comparing measurements from three different regions (antrum, incisura and 
fundus). 
2. To assess blood flow in chronic benign gastric ulcers from pre-treatment 
through to healing. 
3. To assess the relationship between a single systemic levels of growth factors 




Mucosal blood flow was measured with laser Doppler flowmetry during routine 
upper endoscopy. All subjects received conscious sedation in the form of 
intravenous midazolam. Supplemental oxygen was administered and pulse 
oximetry and non-invasive blood pressure monitoring were continuously 
performed on all the subjects. Only haemodynamically stable patients were 
recruited into the study. The Olympus EVIS video-endoscope was used. A 
complete upper gastrointestinal endoscopy was performed with the patients in the 
left lateral position. All patients had fasted overnight. 
The laser Doppler flowmeter was a LASERFLO Blood Perfusion Monitor 
(Vasamedics Inc USA, St Paul Minnesota), using a laser probe of wavelength of 
780 nm and a Doppler shift frequency of 30 Hz - 20 000 Hz. The laser Doppler 
flowmeter was switched on half an hour prior to use, to allow it to 
"warm up". The tip of the probe was held against the white static surface on the 
back of the instrument to zero the instrument. This was in compliance with the 
manufacturer's instructions. Data was captured onto a personal computer and 
subsequently transferred to a database for statistical analysis. The probe was 
passed down the biopsy port and held against the gastric mucosa. To ensure 
consistency in the pressure exerted by the probe, the mucosa was observed to 
indent but the probe was not allowed to buckle. Air insufflation was kept to a 
minimum. The probe was allowed to protrude 2 to 4 cm from the tip of the 
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gastroscope. This allowed for slight movement of the probe with peristalsis and 
reduced the number of un-couplings from the gastric mucosa. On achieving 
stabilty readings were made for one minute. 
Figure 4.1 . The Laserflo BPM2 and the personal computer 
Figure 4.2 The gastroscope with the fibre-optic probe passed down the 
biopsy port 
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4.1 NORMAL STOMACHS 
Patients recruited into this study had been referred for endoscopy but had no 
demonstrable pathology. This group included ten paid volunteers. After 
completing the endoscopic examination of the stomach, readings were made at 
single points on the antrum, incisura and fundus for one minute each after 
stabilisation of the readings. The laser Doppler flowmeter made two readings 
every second. Loss of contact between the probe and mucosa of less than 15 
seconds was ignored. If un-coupling was longer than 15 seconds the initial 
readings were discarded and readings recommenced. 
In four normal stomachs two readings were made at the antrum at sites 
separated by at least 2 cm. These readings were compared to establish the 
degree of spatial variability between readings in the same region of the stomach. 
4.2 GASTRIC ULCERS 
An ulcer was defined as the presence of a mucosal crater with visible loss of 
substance, greater than 1 cm in diameter. Measurements were made at two sites 
on the ulcer circumference as well as at single points on the antrum, incisura and 
fundus. Measurements were not made over the ulcer base. There were two 
reasons for this. Firstly the inflammatory tissue in the ulcer base makes 
measurements difficult to interpret. Secondly, healing commences at the ulcer 
edge and we felt that the state of mucosal blood flow at the ulcer periphery is 
more important than that in the ulcer crater. 
All gastric ulcers were biopsied, to exclude malignancy. Evidence of H. pylori 
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infection was looked for on histo-pathological examination. All ulcer patients were 
empirically treated with eradication therapy and proton pump inhibitors 
(amoxycillin 1 g twice daily, clarithromycin 500 mg twice daily and omeprazole 40 
mg daily for two weeks). Patients were re-endoscoped at approximately six 
weeks to assess healing and repeat the biopsy to exclude malignancy. Laser 
Doppler flowmetric measurements were repeated at the ulcer circumference in 
the unhealed ulcers. In one of the surgically treated ulcers intra-operative 
measurements were made. The operating surgeon fashioned a gastrotomy prior 
to mobilising the stomach. In this way we hoped to eliminate the possibility of 
mucosal blood flow being altered by division of named gastric arteries. The sterile 
probe was held directly on the gastric mucosa surrounding the ulcer through the 
gastrotomy. 
If the ulcer had healed completely no further treatment was given. If the ulcer was 
refractory, acid suppression was continued. Eradication therapy was not 
recommenced unless the biopsy specimen showed persistent H. pylori infection. 
The author personally followed up all the patients. Communication between the 
author and the patients was actively encouraged. Patients were judged to be 
compliant if they attended follow-up regularly. If the author felt that the patients 
were non-compliant he attempted to correct this with personal interviews. The 
role of NSAID use, smoking and alcohol ingestion in gastric ulcer pathogenesis 
were emphasised in these interviews. The role of acid suppression and 
eradication were explained to the patients prior to commencing therapy. Patients 
were encouraged to contact the author at the unit if they were unsure about 
therapy or if they were worried about symptoms. 
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4.3 TECHNICAL PROBLEMS WITH MAKING THE MEASUREMENTS 
During the experiment, technical problems were encountered, which were dealt 
with as they arose. The fact that the author performed all the endoscopies and 
made all the measurements allowed a considerable experience to be acquired. 
Most of the technical problems could be overcome with practice. 
Un-coupling was a significant problem. However with practice it was possible to 
maintain contact between the probe and the mucosa. The site at which it was 
most difficult to ensure adequate mucosal probe contact was the incisura. 
Adequate retro-flexion of the scope was essential to ensure a view of the fundus 
and adequate mucosal probe contact at the fundus. 
Another significant problem was the fragile nature of the fibre optic probe. This 
resulted in breakage, usually after much use. Great care was necessary during 
fundal measurements to prevent acute flexion and excessive angulation with 
subsequent fracturing of the fibres of the probe. 
With experience and care it was possible to regularly obtain stable measurements 
during upper endoscopy. 
4.4 GROWTH FACTOR ASSAYS 
Systemic levels of the following growth factors: bFGF, EGF and TGF-~1 were 
measured in patients who had a gastric ulcer demonstrated on upper endoscopy. 
Each patient was allowed to rest for 30 minutes after the endoscopy, prior to 
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venesection being performed. This was in an attempt to eliminate the 
unpredictable response of these growth factors to the endoscopy. The author 
performed venesection with the patient recumbent, using a vacuum collection 
system. The specimens were kept refrigerated until the end of the endoscopy 
session when they were taken on ice to the laboratory where they were spun 
down. All growth factors were measured using an ELISA procedure. These 
assays employ the quantitative sandwich enzyme immunoassay technique. The 
optical density of each well was read using a micro-plate reader at 450 nm. For 
wavelength correction the micro-plate reader was set at 540 nm. All samples and 
standards were assayed in dulplicate. A thawed sample was used once and then 
discarded. The technique used was the same for all the growth factors measured. 
The technique will be described in detail for TGF-~1. Only variations in the 
technique will be highlighted for the remaining two growth factors. 
4.4.1 TGF-~1 
The blood samples were allowed to clot for one hour at room temperature. The 
samples were then incubated overnight at 4°C before centrifugation. This allows 
for the complete release of TGF-~1. After incubation, the sample was centrifuged 
at 1 000 x g for ten minutes. The serum was removed and aliquotted into equal 
volumes and stored at -70°C. TGF-~ soluble receptor Type II, which binds TGF-
~ 1, was pre-coated onto a micro-plate. A serial dilution of the standards was 
prepared, ranging in concentration from 1000 pg/ml to 31.2 pg/ml. Samples 
(diluted 4-fold) were then pipetted into the micro-plate. TGF-~1 present is bound 
by the immobilised receptor. After washing, to remove unbound substances, an 
enzyme-linked polyclonal antibody specific for TG F-~ 1 was added to the wells to 
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sandwich the TGF-~1 immobilsed during the first incubation. Following a wash to 
remove any unbound antibody-enzyme reagent, a substrate solution was added 
to the wells and the colour was allowed to develop. The colour development was 
in proportion to the amount of TGF-~1 bound in the initial step. The colour 
development was stopped when the intensity of the colour was measured. 
4.4.2 FGF (basic) 
The blood samples were immediately placed on ice and allowed to clot at about 
4°C. The samples were then centrifuged for ten minutes at 1000 x g. The serum 
was removed and aliquotted into equal volumes and stored at :::;-20°C until 
assayed. Before assay, the samples were allowed to thaw for a short period of 
time and immediately placed on ice until assayed. 
4.4.3 EGF 
The blood samples were allowed to clot for 30 minutes at room temperature. The 
samples were then centrifuged for ten minutes at 1 000 x g. The serum was 
removed and aliquotted into equal volumes and stored at -20°C until required. 
Before measurement for EGF, all serum samples were diluted 20-fold. 
4.5 STATISTICAL ANALYSIS 
A professional statistician was consulted for help regarding the presentation and 
statistical analysis of the results. The standard demographic data was analysed 
using a commercial statistics programme. The 120 readings for each one minute 
period were averaged. These average measurements for each patient were 
entered into a database for analysis. All results were expressed as a mean and 
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the standard deviation. Paired and unpaired Student's t test was used to 
compare readings and determine whether differences were statistically 
significant. A p value <0.05 was considered significant. Pearson's correlation test 




5.1 NORMAL STOMACHS 
Readings were made in 105 normal stomachs (median age 51 years, range age 
16-75,65 males and 40 females). Blood flow, volume and velocity increased as 
the probe ascended the stomach from antrum to fundus (Table 5.1) (Appendix 
1). Blood flow and velocity were significantly higher at the fundus than the 
antrum. In the four stomachs in which multiple readings were made at the antrum, 
a close correlation was demonstrated between readings. (Table 5.2). 
Table 5.1. Blood flow, volume and velocity at the antrum, incisura and fundus. 
Antrum Incisura Fundus p Value 
Flow ml/min/1 OOg 59.8 ±26.1 68.4 ± 28.9. 73.8 ± 29.9 * <0.001 
Volume by % * * 7.4 ± 4.4 7.3 ± 3.7 7.8 ± 4.4 >0.05 
Velocity mm/sec * * 3.8 ± 1.4 4.6 ± 1.6 4.9 ± 1.7 <0.0002 
Table 5.2. Correlation of flow readings from different sites on the antrum. 
Site1 Site2 Correlation 
Flow ml/min/100g mlimin/100g 
Patient 1 36.5 ± 3 43.2 ± 2 0.89 
Patient 2 65.4 ± 3 75.6 ± 6 0.78 
Patient 3 20.8 ± 3 30.7 ± 2 0.85 
Patient 4 98.7 ± 3 91.5 ± 1 0.93 
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5.2 BENIGN GASTRIC ULCERS 
5.2.1 Ulcer Demographics 
A total of 26 patients with benign gastric ulcers were recruited . There were no 
associated duodenal ulcers. There were five incisural (lesser curve) ulcers. The 
remainder were pre-pyloric. Seventeen (65%) ulcers had H. pylori infection 
proven on histology. 
5.2.2 Refractory Ulcers 
There were six patients with refractory ulcers (median age 56 years, age range 
35-76 years, five males and one female). Four of these six patients complicated 
and required surgery. In the remaining two patients, the ulcers never healed but 
did not require surgery. Both of these patients had severe co-morbid medical 
problems and both died of their systemic problems within six months of their 
presentation. They did not die from perforation or acute haemorrhage. 
H. pylori, infection was demonstrated on five of the initial biopsies. Successful 
eradication was documented in four of the H. pylori positive patients. Two of the 
patients who complicated were non-compliant on treatment. They both continued 
to smoke, take aspirin and ingest alcohol. H. pylori, was succesfully eradicated 
in one of these patients. The remaining two patients complicated whilst on 
therapy. The operation in all cases was an antrectomy, vagotomy and 
duodenostomy. 
5.2.3 Healed ulcers 
There were 20 patients in this group (median age of 56 years, range 33 to 73 
years, 5 females and 15 males). The average size of the healed ulcers was 2 cm. 
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(range 1 cm to 7 cm). Twelve (60%) of the healed ulcers were H. pylori positive 
on initial biopsy. Healing was taken as evidence of effective eradication therapy. 
One of these ulcers was 7 cm in diameter and located on the lesser curve. 
Healing took 13 weeks in this patient. This patient admitted to heavy ingestion of 
NSAIO's prior to developing her ulcer. NSAIO's were discontinued successfully in 
this patient. In ten patients complete sets of readings were available. In six 
patients, follow-up readings were not made and in four patients there were no 
initial readings available. The reasons for this were multiple. In the latter group 
the initial endoscopy had been performed by clinicians, who were not involved in 
the study. They were subsequently referred to the author's clinic. In the group 
with no follow-up readings, four refused repeat measurements and two patients 
re-scheduled their endoscopy appointment and subsequently underwent 
endoscopy by a clinician not involved in the study. 
5.2.4 Mucosal haemodynamics around ulcers 
The healed ulcers showed significantly higher blood flow than normal gastric 
antrums. This persisted at follow-up. The average time of the second endoscopy 
was 33 days ±9 days. The refractory ulcers showed lower flows than the normal 
antrums and the healed ulcers (Table 5.3) (Appendix 1). The refractory ulcers 
demonstrated persistently lower mucosal blood flow at follow-up. 
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Table 5.3. Differences in blood flow between normal and ulcerated stomachs: 
Flow Flow Flow p Value 
___ ---.-:ml/min/1 OQa~_~J!mi!ll) OQg_~min/1 OO~ ______ . 
Normal Healed Unhealed 
N=105 N=10 N=6 
* * * < 0.003 Initial 59.8±26.1 75.7 ± 17.5 45.2 ± 21.9 
* * * < 0.003 Follow-up 69.8 ± 13.7 39.2 ± 6.7 
5.3 H. pylori AND ULCER HEALING 
Repeat biopsy was used to exclude persistent H. pylori infection in the refractory 
ulcer group. In this group, five of the ulcers were positive for H. pylori at 
presentation. In only one case was H. pylori demonstrated on repeat biopsy. One 
patient developed a re-infection after eight months. The remaining three 
refractory ulcers which had demonstrated H. pylori on initial biopsy were negative 
three months later. In the healed group twelve (60%) patients had H. pylori 
infection proven on initial biopsy, however eradication was not confirmed in these 
patients. 
5.4 GROWTH FACTOR LEVELS 
The systemic levels of bFGF were significantly higher in the healed ulcers, 
compared to the refractory ulcers. TGF-~ 1 was higher in the healed ulcers than 
the refractory ulcers although this did not achieve statistical significance. EGF 
levels were similar in both groups (Table 5.4). 
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23.5 ± 27.8 
11.3 ± 5.9 
<0.01 
TGF pg/ml 
42.3 ± 11.5 
19.7 ± 32.4 
<0.06 
EGF pg/ml 
61.8 ± 30.5 






In this chapter, the literature pertaining to laser Doppler, gastric mucosal blood 
flow and the role of growth factors in gastric healing will be discussed in the light 
of our own findings and those of other authors. 
6.2 SPATIAL REPRODUCIBILITY 
The good correlation between multiple antral readings in individual patients 
implies that laser Doppler flow varies little in this region during a single endoscopy 
session. Long-term correlation between flow measurements was not assessed in 
normals. 
6.3 DISTRIBUTION OF MUCOSAL BLOOD FLOW IN NORMAL STOMACHS 
The distribution of mucosal blood flow seen in our cohort of normal human 
stomachs is similar to that seen by other investigators in animal73-75 and in 
human69,76-78 stomachs. This applies to both laser Doppler flowmetry and other 
techniques of measurement. 
6.3.1 Animal Studies 
The gradient between fundal and antral blood flow is also seen in animals. Kleen 
et al.,73 in splenectomized beagle dogs, found that the stomach has a regional 
variation in its perfusion of 26 ± 22 ml/min/100 g of tissue at the antrum and 67 ± 
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44 ml/min/100 g of tissue at the fundus. Becker et a/?4 reported values of 19 
ml/min/100 g of tissue, and 29 ml/min/100 g of tissue moving from the antrum to 
the fundus. Hottenrott et al.75 reported values of 12 ml/min/100 g of tissue and 35 
ml/min/100 g of tissue at the antrum and fundus. These measurements were all 
made in canine stomachs using the radioactive microsphere technique. The trend 
for blood flow to increase as the stomach is ascended was confirmed in all these 
experiments. Kleen et al.73 stated, "Gastric mucosal blood flow is most probably 
also heterogeneously distributed in humans". The difference in mucosal blood 
flow between the antrum and the fundus demonstrated in our results confirms his 
statement. 
6.3.1 Human Studies 
Investigators have demonstrated a gradient in gastric mucosal blood flow 
between the antrum and fundus in human stomachs by a variety of techniques. 
Kawano et al.79 used reflectance spectrophotometry to estimate mucosal blood 
volume in 55 normal controls. An image of mucosal blood volume distribution was 
made with a two-dimensional computer colour graphics programme. They 
demonstrated higher blood volume at the fundus in comparison to the antrum and 
a higher volume at the lesser curve than the greater curve. 
Kvernebo et al.77 in 34 normal human volunteers demonstrated significantly 
higher blood flow at the fundus than at the incisura and antrum, using laser 
Doppler flowmetry. They did not quantify the difference in their paper. 
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Allen et al.76 documented a significant difference in mucosal blood flow between 
the antrum (44.4 ± 23.3 ml/min/100 g of tissue) and the fundus (74.9 ± 4.8 
ml/min/100 g of tissue), using laser Doppler flowmetry in 38 normal patients. 
Using laser Doppler flowmetry, Gana et al?8 documented higher mucosal blood 
flow at the fundus in comparison to the antrum. Mucosal blood flow in twelve 
patients with either symptoms of dyspepsia or with a peptic ulcer was compared 
with mucosal blood flow in six asymptomatic healthy volunteers. Mucosal blood 
flow was measured for 1 minute at the duodenum, pre-pylorus, antrum, angularis, 
mid-greater curvature, fundus and the distal oesophagus. At all sites mean blood 
flow was 72% of the corresponding value in the volunteers. However in both 
groups blood flow was highest in the fundus and lowest in the antrum. 
Ahn et al.69 in 26 subjects made sequential laser Doppler readings at three 
different sites in the stomach. They documented a significant gradient between 
the fundal and antral readings. The difference in mucosal blood flow between the 
antrum and fundus in these studies is in concordance with our own findings and 
are documented in Table 6.1. (Some laser Doppler flowmeters give 
measurements in volts (V).) 
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Table 6.1. A comparison of different authors results 
Authors Clarke Ahn et al.69 Allen et al. 76 Gana et al. 78 
Patient No 105 26 38 12 
Laser Vasamedics Periflux PF1 and Periflux PF2 Periflux PF3 
Doppler BPM2 PF2 
Units ml/m/100g Volts Volts Volts 
Antrum 59.8 ± 26.1 69.3 ± 21.9 44.4 ± 23.3 17.3 ± 3.3 
Incisura 68.4 ± 29.9 83.6 ± 24.7 Not reported Not reported 
Fundus 73.8 ± 29.9 95.4 ± 21.3 74.9 ± 44.8 28.3 ± 0.9 
The physiological explanation for the higher blood flow at the fundus and greater 
curvature is unclear. It may be a feature of the higher level of functional activity of 
the fundus, the region of acid production, in comparison to the less physiologically 
active antrum and most likely reflects the active neutralisation of back diffusing 
Hydrogen ions in the region of acid production. 
6.4 AN ANATOMICAL EXPLANATION FOR THE GRADIENT IN GASTRIC 
MUCOSAL BLOOD FLOW 
Barlow et al.
80 
in 1951 demonstrated differences in the micro-vascular anatomy of 
the fundus and antrum, which offer some explanation for the regional perfusion 
differences in the gastric mucosa. Angiographic assessment of post mortem 
stomachs demonstrated the arteriole branches of named arteries piercing the 
muscle coat and forming an anastomosing network in the submucosa. The 
arterioles supplying the antrum and proximal duodenum are shorter and finer with 
fewer anastomoses compared to those supplying the rest of the stomach. In the 
antrum the submucosal plexus has on average a smaller diameter (100-150 /-Lm) 
in comparison to that of the fundus (150-200 /-Lm). Furthermore the mucosal 
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arteries are much smaller diameter or length or both in the antrum than the 
fundus although the arrangement is similar. In the region of the lesser curve 
mucosal arteries do not arise from a submucosal plexus but have their origins 
outside the stomach directly from the right and left gastric vessels. These slender 
vessels pierce the stomach wall to enter the submucosa, which they traverse 
obliquely without forming a submucous plexus to reach the mucosa. Here a 
mucosal plexus is formed. This end arteriole system may be more prone to 
develop reduced mucosal blood flow than the rich plexus found in the submucosa 
of the fundus. The difference in size of the submucosal arterioles of the fundus 
and antrum reflects the lower blood flow at the antrum in comparison with the 
fundus. 
Barlow et al. demonstrated direct arterio-venous channels of 140 Jlm in diameter, 
commonly arising from the mucosal arteries. According to them., the distribution 
of mucosal blood flow depends on two types of resistance placed in parallel: the 
submucosal arterioles and the proximal shunts. This means that blood can be 
diverted from one part of the stomach to another in compliance with different 
functional requirements. The role of these arterio-venous shunts remains 
enigmatic. Gannon et a/. 81 failed to demonstrate arterio-venous anastomosis by 
means of partial vascular casting and scanning electron microscopy. They went 
on to state, "If anyone wishes to evoke arterio-venous shunts they must provide 
unequivocal structural evidence of their existence". 
Despite the controversy concerning the existence of the shunts, Barlow et a/. 
provide evidence of regional anatomical differences which could explain the 
variations in mucosal blood flow measured in this and other studies. 
6.5 GASTRIC MUCOSAL BLOOD FLOW IN BENIGN GASTRIC 
ULCERATION 
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In principle, gastric ulceration results from an imbalance between the digestive 
action of acid and pepsin on the mucosa and the protective mechanism in place 
to resist mucosal digestion. Alterations in gastric mucosal haemodynamics play 
an important role in the pathogenesis and healing of gastric ulcers. This is well 
documented in the case of acute stress-related ulcers, which develop secondary 
to hypotension.82 Clinically, most patients who develop stress ulcers have 
experienced an episode of shock from haemorrhage, sepsis, or cardiac 
dysfunction. Diminished mucosal blood flow is the common denominator in 
animal experiments that employ restraint, haemorrhage, or endotoxaemia to 
produce acute lesions. Gastric mucosal blood flow plays an important role in the 
disposal and buffering of the Hydrogen ions diffusing across the mucosa. 
Reduced mucosal blood flow impairs the capacity of the gastric mucosa to 
neutralise acid. This in turn leads to accumulation of Hydrogen ions within the 
mucosa and ulceration.25 
The role of reduced mucosal blood flow in chronic ulceration is less well defined. 
We have documented reduced mucosal blood flow around refractory gastric 
ulcers, and enhanced mucosal blood flow in the case of healing ulcers. We 
believe this to be evidence that mucosal blood flow plays an important role in 
chronic as well as acute ulceration. 
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6.6 COMPARISON WITH THE RESULTS OF OTHER INVESTIGATORS 
Other investigators have looked at the role of gastric mucosal blood flow in 
benign gastric ulceration in both animals and humans using a variety of 
techniques. Lunde and Kverneb083 measured mucosal blood flow in 15 patients 
with chronic gastric ulcers, using laser Doppler flowmetry. They demonstrated 
lower blood flow along the lesser curve in comparison to the greater curve. At 
follow-up the low blood flow persisted. At a subsequent follow-up the blood flow 
had significantly increased along the lesser curve, however flow at the ulcer 
remained low. At four to six weeks ten ulcers were healed and at four months, 
twelve ulcers were healed. 
Kamada et al.84 using reflectance spectrophotometry, measured mucosal blood 
volume in 42 patients with benign gastric ulceration. They repeated these 
measurements at regular intervals during ulcer healing. During the active phase 
of ulceration blood volume was diminished in all regions of the stomach, in 
comparison with normal stomachs. However during ulcer healing, peri-ulcer blood 
volume increased. In the healed ulcers, peri-ulcer blood volume increased by 
33%. In the non-healed ulcers, peri-ulcer blood volume only increased by 3%. It 
would appear that these ulcers were treated with antacids. These results imply 
that reduced mucosal blood flow is important in the pathogenesis of gastric ulcers 
and that a local increase in mucosal blood flow plays an important role in the 
healing of gastric ulceration. 
Sato et al.85 used laser Doppler flowmetry, reflectance spectrophotometry and 
Hydrogen clearance to measure changes in gastric mucosal blood flow in 42 
50 
patients with ulcers. They showed that at the active ulcer stage the index for 
blood volume at the ulcer margin was significantly lower than in normal controls. 
However it increased during ulcer healing to reach a level 30% higher than 
normal antral flow. In the early scarring stage they found that mucosal blood flow 
was still elevated and only returned to normal at the late scar stage. Furthermore 
they showed that the mucosal blood volume index in intractable ulcers was not 
increased. 
Results from Kamada et al.84 and Sato et af5 are in contrast to the findings of 
Lunde and Kvernebo83 but are in agreement with ours. It would appear from our 
results and those of Sato et al.85 and Kamada et al.84 that benign gastric 
ulceration is associated with fluctuations in mucosal blood flow and volume during 
both the acute and healing stages of the disease. An understanding of mucosal 
defence and healing is essential for interpretation of the results of mucosal blood 
flow measurements. 
6.7 MUCOSAL BLOOD FLOW AND THE GASTRIC MUCOSAL BARRIER 
The integrity of the gut depends on preservation of existing tissue and 
replacement of lost tissue. Both of these functions are dependent on mucosal 
blood flow. Preservation of existing cells may be achieved either by enhancing 
the resistance of the cells or by decreasing contact time between the gastric 
mucosa and noxious stimuli. In the gastric mucosa the main method of 
preservation involves rapid clearing of the noxious substance. This is achieved by 
rapid gastric emptying and by maintaining adequate blood flow and mucous and 
bicarbonate secretion. Maintenance of gastric mucosal blood flow is essential for 
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these processes to occur. 
Lost or damaged epithelial cells may be replaced by epithelial cells or by 
connective tissue. Restitution involves in-growth of cells from the edge of the 
lesion. In cases of superficial mucosal damage where blood flow is maintained, 
the partly damaged and healthy epithelial cells respond by migrating to cover the 
epithelial defect.26 Deep necrosis causes cessation of blood flow in a relatively 
large area. This requires replacement by proliferating connective tissue cells such 
as fibroblasts, macrophages and collagen. Proliferation is accompanied by 
angiogenesis. Inflammatory cells remove the necrotic tissue. Once a new scaffold 
of granulation tissue has been laid down, re-epithelialisation can OCCUr. 26 
Both gastric defence and healing are energy dependent processes, which require 
adequate nutrient and oxygen supply. If mucosal blood flow is reduced then 
mucosal defence and healing is impaired. 
6.8 MUCOSAL ADAPTATION AND CYTO-PROTECTION 
The gastric mucosa shows a remarkable ability to adapt to injury. The application 
of low doses of mild irritants significantly prevents the development of gastric 
ulceration produced by higher concer;ltrations of the same or different agents. 
This protection is mediated by an increase in gastric mucosal blood flow in 




induced gastric adaptation in rats by repeated daily doses of 
acidified amino-salicyclic acid (ASA), given intra-gastrically. This group was 
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compared to control rats with intact stomachs, which were given a non-reactive 
vehicle only. After five days of ASA, the rats were challenged with either acidified 
ASA or with strong irritants such as 100% ethanol, 200 mmol acidified 
taurocholate, 25% NaCI for one hour, or with water immersion and restraint. The 
first dose of ASA produced numerous gastric lesions and deep histological 
necrosis. These were accompanied by a fall in the gastric blood flow, and 
negligible expression of EGF and TGF-a or their receptors. There was no 
evidence of mucosal proliferation. However, as adaptation to ASA developed the 
areas of gastric ulceration were reduced by more than 80%. There was a 
noticeable decrease in deep necrosis, a partial restoration of gastric blood flow, 
an approximately 4-fold increase in EGF expression and its receptors. There was 
an appreciable increase in mucosal cell proliferation compared with vehicle 
treated rats. Increases in the mucosal expression of EGF receptors and the 
luminal content of EGF were also found in ASA-adapted animals. When the ASA-
adapted rats were challenged, the area of deep histological necrosis and gastric 
ulceration, was reduced in comparison to the control rats. This increased mucosal 
tolerance to strong irritants was also accompanied by the return of the gastric 
blood flow towards control levels and further significant increases in the mucosal 
expression of EGF receptors and mucosal cell proliferation. They concluded that 
gastric adaptation to ASA enhances mucosal resistance by restoring gastric blood 
flow and increasing cell proliferation. 
Gastric mucosal adaptation is highly blood flow dependent. Svanes et al.87 
demonstrated an increase in mucosal blood flow in cats, when the feline stomach 
was pre-treated with a mild irritant. This pre-treatment reduced the damage to 
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the gastric mucosa caused by exposure to absolute ethanol. In a third group, the 
coeliac artery was partially occluded. This served to prevent an increase in 
mucosal blood flow following pre-treatment with the same irritant. In this group of 
cats, pre-treatment offered no protection against absolute ethanol. They stated 
that "high mucosal blood flow represents a very important factor in adaptive cyto-
protection". 
Once blood flow is impaired, adaptation cannot occur and mucosal injury 
develops. Starliilger et al.88 showed that when the gastric mucosa of rabbits was 
exposed to increasing luminal acidity and increasing Hydrogen ion back diffusion, 
mucosal blood flow increased, whilst intra-mucosal pH remained constant. When 
hypovolaemic shock was induced, increasing luminal acid resulted in reduction of 
intra-mucosal pH and subsequent mucosal ulceration. 
Ritche and Shearburn89 showed that a large gradient of Hydrogen ion 
concentration between the lumen and mucosa could be tolerated provided there 
was adequate mucosal blood flow to sweep away the influxing Hydrogen ions. If 
gastric mucosal blood flow is impaired, then mucosal adaptation is inhibited and a 
gastric ulcer will develop. 
Mucosal blood flow is an important mechanism in preventing mucosal injury. An 
increase in mucosal blood flow facilitates healing and restoration of mucosal 
integrity. Our findings of increased mucosal blood flow in healing gastric ulcers is 
in keeping with our understanding of the changes in mucosal blood flow in 
response to mucosal injury. 
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6.9 IMPAIRMENT OF BLOOD FLOW AND ULCER FORMATION 
Impairment of gastric mucosal blood flow prevents mucosal adaptation and 
inhibits mucosal defence. There is experimental evidence linking impairment of 
mucosal blood flow with the formation of gastric ulcers. Szabo et al.
90 
assessed 
the effect of hypotension on mucosal blood flow in anaesthetised dogs. Blood 
flow in the portal vein and the left gastric artery was measured 
electromagnetically and gastric mucosal perfusion was determined by 
pertechnetate clearance. Bleeding the animals to arterial pressures of 100 and 
60 mmHg reduced portal venous flow and increased the mesenteric in-flow 
resistance. Left gastric arterial and gastric mucosal blood flow were decreased. 
Gastric acid secretion decreased but did not stop even at the lower level of 
haemorrhagic hypotension. They concluded that acid precipitated stress 
ulceration only in the presence of hypotension and reduced mucosal blood flow. 
Sato et al. 91 investigated the gastric mucosal blood flow with an in vivo 
microscopic analysing system and reflectance spectrophotometry. Topical 
administration of either 20% ethanol, indomethacin, leukotriene C4 or platelet 
activating factor (PAF) decreased mucosal blood flow and mucosal blood 
oxygenation. The subsequent application of hydrochloric acid (HCL) induced 
gastric bleeding and ulceration. They concluded that gastric mucosal blood flow 
plays an important role in the mucosal protection. In further experiments they. 
admin istered indomethacin intravenously and a solution of ethanol and HCL 
topically to rats. They observed the effect on gastric mucosal blood flow with laser 
Doppler, Hydrogen clearance, aminopyrine clearance and in-vivo microscopy. 
Similar experiments were performed in mongrel dogs. Indomethacin in the dogs 
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decreased mucosal blood flow in the capillaries and collecting venules. However 
the gastric mucosal lesion one hour post treatment was small. Only petechiae 
were seen in the gastric fundus. In rats pre-treated with indomethacin, topical 
administration of HCL caused blood flow to stop and in some regions even 
reverse from the venules to the capillaries. 
When 40% ethanol was administered to the anaesthetised rat, circulation became 
slow in the surface mucosa. The venules became engorged and white cells 
marginated, rolled and stacked the endothelium so blocking the flow of red cells. 
These changes were not evenly distributed throughout the stomach. 
Chung et al. 92 showed that mucosal lesions occurred in rats when mucosal blood 
flow was reduced to 40% of baseline levels. Varhaug and Svanes93 reduced 
regional mucosal blood flow by partial devascularisation of the feline stomach. He 
measured pentagastrin-stimulated acid secretion and gastric mucosal blood flow, 
by means of the microsphere distribution technique, two hours and at one week 
after partial gastric devascularisation. Systemic cardiac output was also 
determined. Devascularisation decreased the volume but not the pH of acid 
secreted by the stomachs. Mucosal blood flow was markedly reduced two hours 
post devascularisation. After one week, blood flow had improved and was not 
significantly different from controls. The ratio of acid secretion to mucosal blood 
flow was not Significantly changed one week after devascularisation as compared 
with the acute experiments. However all cats examined one week after 
devascularisation had developed ulcers at the mid-portion of the greater 
curvature. This was the area of the gastric mucosa that had the most markedly 
56 
reduced mucosal blood flow. These ulcers could be prevented by acid inhibition. 
In other words the ulcers arose in a situation of normal luminal acid concentration 
but with inhibited mucosal defence. 
Kalia et al. 94 and Kalia and Bardhan95 used fluorescent in vivo microscopy to 
directly examine the response of several areas of gastric mucosa to 0.5 ml of 
60% ethanol in animals. Their findings suggested a close correlation between 
vascular stasis and mucosal necrosis. The entire mucosal circulation showed an 
increase in leakage of fluoroscein-Iabelled albumin following exposure to 60% 
ethanol. This reflected extensive micro-circulatory disruption. However gross 
ulceration was seen in small areas only. In the peri-ulcer mucosa leakage of 
macro-molecules increased after exposure and remained significantly higher than 
normal for the duration of the experiment. In areas remote from the ulceration, 
macro-molecular leakage was seen to increase but declined rapidly thereafter, 
although it remained higher than pre-treatment levels. The areas where mucosal 
ulceration developed showed persistent haemostasis. 
Pihan et al. 96 used in vivo microscopy and laser Doppler flowmetry to examine the 
effects on gastric mucosal blood flow of agents known to induce acute gastric 
mucosal damage. In vivo microscopic observation of superficial mucosal 
capillaries revealed vascular stasis within 54 seconds following the application of 
100% ethanol, and the subsequent development of mucosal lesions. Mucosal 
blood flow as measured by laser Doppler flowmetry decreased by 30% at five 
minutes after application of 100% ethanol, and decreased further to about 40% of 
basal levels by 15 minutes. Decreased mucosal blood flow correlated with the 
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development of mucosal lesions. 
All these data support the role of impaired mucosal blood flow in the 
pathogenesis of acute benign gastric ulceration. Decreased mucosal blood flow 
results in impaired buffering of Hydrogen ions and impaired mucosal defence so 
allowing unopposed exposure of the mucosa to gastric acid. Inhibition of mucosal 
blood flow disrupts the gastric mucosal barrier and inhibits mucosal cyto-
protection with an end result of mucosal ulceration. Whilst the role of reduced 
mucosal blood flow in acute gastric lesions is well documented, its role in chronic 
ulceration is less clear. There is work looking at the effect of various factors which 
are associated with peptic ulceration on mucosal blood flow. These studies shed 
some light on the role of mucosal blood flow in the pathogenesis of benign 
chronic gastric ulceration. 
6.10 THE EFFECT OF NSAID'S AND CIGARETTE SMOKE ON GASTRIC 
MUCOSAL BLOOD FLOW 
Under pathological conditions, various stimuli or the lack of physiological 
regulators can disturb gastric mucosal blood flow. NSAID use and cigarette 
smoke are both implicated in the pathogenesis of gastric ulceration and both 
factors have been shown to affect mucosal blood flow. 2o,97,98 NSAID's are 
believed to decrease mucosal prostaglandin levels by inhibiting cyclo-
oxygenases. This decreases mucosal blood flow and bicarbonate secretion and 
this in turn impairs mucosal ability to neutralise back diffusing Hydrogen ions. 
NSAID use has been shown to decrease mucosal blood flow. 
Ashley et al.
99 
demonstrated that exposure to aspirin reduces gastric mucosal 
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blood flow. He compared focal gastric mucosal blood flow as measured by the 
Hydrogen gas clearance method, with total gastric blood flow as determined by 
venous outflow in an isolated segment of canine stomach before, during, and 
after exposure to aspirin. Despite an increase in total gastric blood flow and an 
increase in mucosal blood flow at non-ulcerated sites on the gastric mucosa, 
mucosal blood flow at the site of aspirin-induced ulceration was significantly 
reduced. After removal of aspirin, mucosal blood flow returned to control levels. 
Such a redistribution of mucosal blood flow in response to aspirin is consistent 
with the localised nature of acute aspirin-induced injury, and demonstrates that 
impaired mucosal blood flow is necessary for the development of a peptic ulcer. 
Taha et al.100 used laser Doppler flowmetry to measure gastric and duodenal 
mucosal blood flow in 70 patients who had taken NSAID's for longer than four 
weeks. They also studied the correlation with demographic factors, ulceration, H. 
Pylori infection and cigarette smoking. These readings were compared with 
readings made in 17 subjects not taking NSAID's. Both gastric and duodenal 
blood flow values were significantly lower in patients taking NSAID's, than in 
those who were not. The median duodenal mucosal blood flow was significantly 
lower in smokers than non-smokers. Similarly, blood flow was significantly lower 
in patients with duodenal ulcers in comparison to those without duodenal ulcers. 
Sawant et al. 101 assessed the effect of a short course of indomethacin on gastric 
mucosal blood flow. Patients with musculo-skeletal pain of recent origin who had 
been prescribed a course of indomethacin for 7 days were investigated. Baseline 
measurements of gastric mucosal blood flow were carried out with laser Doppler 
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flowmetry prior to commencing indomethacin. Measurements were made at the 
antrum, incisura, lesser and greater curves, and fundus. These measurements 
were repeated after therapy was completed. The flow was measured at the same 
sites and at the site of any erosion. In ten out of the sixteen patients, gastric 
mucosal erosions developed. Mean gastric mucosal blood flow at the sites of 
erosion was significantly reduced. This implies that NSAID use decreases 
mucosal blood flow in the stomach, and that this decrease in blood flow is 
associated with the development of peptic ulceration. These results imply that 
decreased mucosal blood flow is a feature of cigarette smoke and NSAID use. 
Cigarette smoking and has been shown to decrease mucosal blood flow and so 
predispose to gastric ulceration.21 ,97,102-104 Guslandi et al. 21 documented 
decreased mucosal blood flow in the stomachs of smokers. In 20 dyspeptic 
patients (ten non-smokers and ten smokers) without duodenal pathology, 
mucosal blood flow was measured in the duodenal bulb by laser Doppler 
flowmetry. Basal bulbar perfusion was found to be significantly lower in smokers. 
This reduction in duodenal blood flow seen in smokers may promote duodenal 
damage secondary to an impaired ability to neutralise back-diffusing Hydrogen 
ions and reduced secretion of protective bicarbonate. 
Battistel et al.
104 
showed that the intake of nicotine induces vascular damage in 
the rat gastric mucosa. In this study rats were treated with nicotine added to their 
drinking water, for 50 days. They were then anaesthetised and their stomachs 
perfused with ASA. Basal blood flow in the gastric mucosa was unchanged by 
chronic nicotine intake, however the mucosal hyperaemia usually evoked by the 
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ASA induced acid back diffusion was averted. The concentration of 
sulfidoleukotrienes in the gastric wall of nicotine treated rats was significantly 
augmented. These data show that chronic nicotine intake causes dysregulation of 
the gastric mucosal blood flow, an effect that is associated with biochemical 
changes in the stomach. This study suggests that inappropriate regulation of 
gastric mucosal blood flow may inhibit recovery from gastric mucosal injury in 
smokers. 
Both NSAIO's and cigarette smoke have been shown to decrease gastric mucosal 
blood flow in a variety of experiments. These two factors are known to be closely 
associated with gastric ulceration. More importantly these factors appear to be 
closely linked to the problem of refractory ulceration. In our group of refractory 
ulcers, mucosal blood flow was significantly lower than in healing ulcers and 
normal stomachs. The implication of our findings and the above results is that 
impaired mucosal blood flow is an important factor in the pathogenesis of gastric 
ulceration and in the development of refractory ulceration. Furthermore, 
modification of lifestyle factors that are known to impair mucosal blood flow 
should be emphasised and addressed as part of the primary therapy for patients 
with gastric ulcers. This becomes even more important if the patients are part of a 
high-risk group, such as the group identified in this study. 
6.11 THE MEDIATION OF GASTRIC MUCOSAL HYPERAEMIA AND 
HEALING 
Mucosal defence and healing are dependent on adequate blood flow. The results 
from our study reflect the important role of mucosal blood flow in mucosal 
defence and healing. The gastric ulcers that healed all had higher mucosal blood 
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flow than the normal antrums. This represents gastric mucosal adaptation and 
cyto-protection. Experiments using a variety of mediators confirm that 
enhancement of mucosal blood flow is important to attenuate the extent of acute 
mucosal damage and to promote mucosal healing. 
Mediators of enhanced mucosal blood flow include prostaglandins and Nitric 
Oxide. The pathways by which these effects are mediated include central vagal 
and local pathways. A great deal of experimental work has been undertaken 
using various mediators of mucosal blood flow.31 ,105-106 These data provide insight 
into the role of mucosal blood flow in gastric mucosal healing and protection. 
Brozozowski et al.31 demonstrated an acceleration of gastric ulcer healing 
following administration of L-arginine, a pre-metabolite of nitric oxide, in a dose-
dependent manner. The accelerated healing was accompanied by a marked 
increase in gastric blood flow at the ulcer margin. Furthermore, increased serum 
gastrin, increased mucosal DNA synthesis, and angiogenesis in the granulation 
tissue in the ulcer bed were also seen. A similar improvement in ulcer healing 
associated with enhanced mucosal blood flow at the ulcer margin and enhanced 
angiogenesis, was observed after treatment with the nitric oxide supplier glyceryl-
trinitrate. In contrast an inhibitor of nitric oxide synthase, NG-nitro-L-arginine (L-
NNA), delayed ulcer healing. This was accompanied by a reduction in mucosal 
blood flow at the ulcer margin. Angiogenesis in granulation tissue, serum gastrin 
level and mucosal growth were also decreased. The addition of L-arginine to L-
NNA restored ulcer healing, and enhanced mucosal blood flow at the ulcer 
margin. Pre-treatment with indomethacin, which inhibits synthesis of 
62 
prostaglandins, also delayed ulcer healing. This was reversed by the co-
administration of L-arginine. 
Panes et al. 105 investigated the role of endogenous nitric oxide as a mediator of 
mucosal blood flow. The application of NG-monomethyl-L-arginine (L-NMMA), 
which is a specific inhibitor of nitric oxide biosynthesis, attenuated in a dose-
related manner the increase in gastric mucosal blood flow, which is usually 
induced by haemodilution. The concurrent administration of L-arginine (the 
precursor of nitric oxide biosynthesis) abolished the effects of L-NMMA on gastric 
mucosal blood flow. L-arginine accelerates ulcer healing by enhancing gastric 
mucosal blood flow. 
Battal et al. 107 examined the effects of beraprost sodium (a chemically stable 
prostaglandin 12 (PGI2) analogue) on burn-induced gastric mucosal changes in 
rats. Twenty male rats were burned and then divided into two equal groups. One 
group received beraprost sodium intra-peritoneally immediately after burn injury, 
while the control group received the same volume of saline. Gastric mucosal 
blood flow was measured with a laser Doppler flowmeter. The area of mucosal 
necrosis was determined macroscopically and histologically. Gastric mucosal 
damage was significantly reduced in the rats treated with beraprost sodium and 
gastric mucosal blood flow was significantly improved. These findings 
demonstrate that PGI2 plays an important role in the pathophysiology of burn-
induced ulcers and that beraprost sodium can improve gastric mucosal blood flow 
and reduce mucosal damage. 
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Rebamipide is a prostaglandin analogue that has been approved for treatment of 
peptic ulcers in Japan. Arakawa et al. 108 compared male Wistar rats, which had 
been pre-treated with Rebamipide, to rats pre-treated with carboxy-
methylcellulose. The rats were scalded and sacrificed 15 minutes after the event. 
The group treated with Rebamipide demonstrated a significantly lower 
percentage of rolling leucocytes in the mucosa than the control group. 
Rebamipide also decreased the amount of endothelial damage. It seems that 
Rebamipide preserved gastric mucosal blood flow by inhibiting leucocyte 
adhesion and endothelial damage in venules at an early stage of thermal-induced 
ulceration. 
These diverse mediators all influence mucosal healing and protection by 
enhancing mucosal blood flow. This emphasises the importance of enhanced 
mucosal blood flow in mucosal protection. Enhanced mucosal blood flow 
supports healing. We have demonstrated enhanced mucosal blood flow in the 
healed ulcers in our study. The 20 healed ulcers, had significantly higher mucosal 
blood flow than the normal antrums. The non-healing ulcers on the other hand 
demonstrated reduced mucosal blood flow. This represents failure of mucosal 
restitution and re-epithelialisation. If angiogenesis does not takes place, new in-
growth of fibroblasts and epithelial cells cannot occur. Inhibition of mucosal blood 
flow prevents healing. Reduced supply of bicarbonate allows accumulation of 
Hydrogen ions and acidification of the mucosa. This leads to mucosal ulceration. 
Without adequate nutrient supply, the high energy demanding process of 
restitution cannot take place. Inhibition of gastric mucosal blood flow was 
demonstrated in the group of non-healing ulcers. These six ulcers had 
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persistently lower mucosal blood flow than normal. 
6.12 LOCATION OF GASTRIC ULCERS 
The majority of human gastric ulcers occur distally in the stomach on the antrum 
and lesser curvature. 109 Wright et al.4o in a review of gastric ulceration, had a 
distribution of gastric ulcers of 61 % lesser curve, 5% antral, 26% pre-pyloric and 
only 8% in the body. The ulcers in our series were all located in the lesser curve 
or pre-pyloric region. There were no greater curve ulcers and no fundal ulcers. 
This is consistent with a review by Wright et al.40 as well as other studies. 109 
Various explanations have been advanced for the distal location of gastric 
ulceration. Oi et al. 109 explained the location of gastric ulceration on the basis of 
the relationship between mucosa and circular muscle fibres at the border of the 
fundus and pylorus. They implicated kinetic strain due to gastric motility of the 
oblique and circular muscle at this point in gastric ulcer pathogenesis. This theory 
has not been confirmed by more recent investigators. 
It seems more likely that lower mucosal blood flow at the antrum may contribute 
to the higher rate of ulceration in the distal stomach compared to the proximal 
stomach. This hypothesis is supported by Barlow et al whose anatomical data 
demonstrates differences between the antral and fundal mucosal blood flow.8o 
The gastric antrum and incisura have relatively lower blood flow in relation to the 
rest of the stomach. This is the region of non-acid production. Decreased 
mucosal blood flow in this region may make the antrum more susceptible to 
mucosal damage. The lesser curve and duodenum are supplied by end arteries 
and it is feasible that occlusion of these arteries may lead to localised regions of 
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reduced mucosal blood flow, which may predispose the antrum to gastric 
ulceration.so 
6.13 H. pylori AND MUCOSAL BLOOD FLOW 
The influence of H. pylori on gastric mucosal blood flow is unclear. Guslandi et 
al. 11o compared gastric mucosal blood flow in ten patients with H. pylori positive 
gastritis and ten patients with H. pylori negative gastritis. They found that both 
groups had similarly decreased antral mucosal blood flow in comparison to 
normal stomachs. Even after eradication the blood flow did not increase to the 
level seen in the normal stomachs. They felt that H. pylori infection had no effect 
on gastric mucosal blood flow and that the pathogenic mechanism of H. pylori 
does not seem to be mediated by alterations in mucosal blood flow. 
Atuma et al. 111 however came to the opposite conclusion by demonstrating that 
antigenic extracts from a variety of H. pylori sub-types lowered mucosal blood 
flow in rats as compared to an extract of E. coli. Bacterial extracts were applied to 
the gastric mucosa of anaesthetised rats. Blood flow was measured by means of 
laser Doppler flowmetry. All the H. pylori extracts significantly reduced gastric 
mucosal blood flow, whereas the E. coli extracts did not. They concluded that a 
combination of factors released from H. pylori, might compromise the natural 
defence of the gastric mucosa by reducing mucosal blood flow and so predispose 
to ulceration. 
Taha et al. 10o also looked for a correlation between peptic ulceration, and H. pylori 
in his cohort of 70 patients on NSAID's. Patients infected with H. pylori had 
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significantly lower gastric and duodenal blood flow than subjects without an 
infection. 
In our cohort, the healed group had a rate of H. pylori infection of 60%, and in the 
non-healed group the rate was 83%. However the healed ulcer group all had a 
higher blood flow than normal stomachs, despite the high incidence of H. pylori 
infection. It is difficult to comment on the effect of H. pylori on mucosal blood flow 
from our data. However the presence of H. pylori does not preclude an increase 
in mucosal blood flow in the injured mucosa. 
6.14 REFRACTORY GASTRIC ULCERATION: THE ROLE OF LASER 
DOPPLER 
Despite the current understanding of gastric ulcer pathogenesis and the 
therapeutic agents available, refractory ulceration remains a clinical problem. 
Despite adequate eradication and therapy, gastric ulcers remain difficult to heal.45 
In our cohort of refractory gastric ulcers eradication did not result in ulcer healing 
in four out of six patients. Of these four ulcers, three went on to require surgery. 
Refractory gastric ulceration is a cause of morbidity and mortality. 
When dealing with refractory gastric ulceration a diligent search for a cause must 
be undertaken. Careful assessment of the efficacy of H. pylori eradication is 
essential. Absence of H. pylori on biopsy four to eight weeks after eradication 
therapy has been discontinued, reliably indicates successful eradication.45 
NSAID use must be reliably excluded. The abuse of aspirin is a common cause of 
refractory and recurrent ulceration. This use is often surreptitious and therefore it 
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is advisable to question family members about aspirin ingestion and to assess 
serum salicylate levels. 11 2 
A higher dose of proton pump inhibitors (Omeprazole 40 mg rather than 20 mg) 
has been shown in uncontrolled trials to be more effective in refractory gastric 
ulceration.45,113 Despite attention to these factors, refractory gastric ulcers will 
frequently require surgery. 
The parameters commonly used to predict non-healing of gastric ulcers remain 
clinical and often anecdotal. These include ulcer size and position as well as the 
patient's compliance and ability to modify lifestyle risks. Large ulcers (>5 cm in 
diameter) tend to take longer to heal. Healing can however still be achieved in 
these patients. Size alone is therefore an inadequate predictor of healing. Ulcers 
in atypical positions have a higher incidence of malignancy. All gastric ulcers, but 
especially atypical ulcers, must be followed to healing by endoscopy and biopsy. 
The patients who are likely to have non-healing ulcers often have a lifestyle that 
prevents compliance. They are often unemployed with a strong history of alcohol 
and cigarette use. Attempting to alter lifestyle risk factors in these patients is 
difficult. 
Predicting refractory ulceration may have important clinical benefits. Ulcers that 
are predicted to be refractory, may be placed on more intensive medical therapy 
at the outset (higher doses of proton pump inhibitors or combination of sucralfate 
with acid suppression). It may be beneficial to tailor H. pylori eradication therapy 
to the individual patient, by culturing the bacteria and determining individual 
68 
sensitivity. More intensive surveillance may be instituted (earlier follow-up 
endoscopy) and a greater effort may be made to encourage modification of 
lifestyle risks and ensure compliance. It may even be necessary to offer earlier 
surgery to patients who are likely to complicate. 
A simple clinical tool to predict non-healing would be useful in these patients. We 
have identified an independent and quantifiable factor, which seems to predict 
non-healing of gastric ulcers. Persistently attenuated mucosal blood flow implies 
that the ulcer will not heal. It may be that laser Doppler has a role to play in 
stratifying patients with gastric ulcers into risk groups. It is too early to propose 
using laser Doppler measurements to make therapeutic decisions. However 
further prospective work to document the positive predictive value of these 
readings is warranted. 
6.15 THE ROLE OF GROWTH FACTORS IN GASTRIC MUCOSAL HEALING 
We compared systemic levels of these growth factors between patients with the 
non-healing gastric ulcers and those with healing gastric ulcers. This section 
discusses our findings with regard to the specific growth factors in light of other 
investigators findings. 
6.16 FIBROBLAST GROWTH FACTOR 
Szabo et al.
32 
investigated the role of FGF in peptic ulceration. They used human 
bFGF, which had been stabilized to acid and pepsin by site-specific mutagenesis, 
to assess whether bFGF might accelerate the healing of experimental duodenal 
ulcers. This mutein peptide (bFGF-CS23) was administered orally to rats with 
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chronic cysteamine induced duodenal ulcers. This group was compared to · a 
group with chronic cysteamine-induced ulcers which was given only cimetidine. 
Oral bFGF-CS23 therapy maintained for 21 days resulted in a significant 
acceleration of healing of the duodenal ulcers, as compared to rats undergoing 
therapy with cimetidine and in untreated controls. Healing of the duodenal ulcers 
was assessed by measuring the reduction in mean ulcer area. Complete healing 
with no residual ulcer was achieved in 62% of the bFGF-CS23 treated rats 
compared with only 7% of untreated rats. A nine-fold increase in angiogenesis in 
the ulcer bed was seen in the bFGF-CS23 treated group in comparison to 
untreated controls. A single dose of the bFGF-CS23 mutein had no effect on 
gastric output of hydrochloric acid or pepsin, but daily treatment for two or three 
weeks resulted in enhanced acid and pepsin outputs. 
Folkman et al.52 demonstrated that bFGF exists as a naturally occurring peptide 
in rat and human gastric and duodenal mucosa, and is also present in the bed of 
chronic ulcers in rats. Sucralfate binds bFGF and protects it from acid 
degradation. Sucralfate is angiogenic as it protects bFGF from acid breakdown 
so prolonging its effect. When sucralfate is administered orally to rats, it 
significantly elevates the level of bFGF in the ulcer bed. Cimetidine, by its 
capacity to reduce gastric acid, elevates bFGF in the ulcer bed by reducing 
breakdown of bFGF by the gastric acid. 
Konutrek et al.
114 
showed in rats that bFGF and the presence of an intact 
omentum accelerated ulcer healing and angiogenesis. Several series of rats with 
gastric ulcers were used: Series A with intact omentum was the control group, 
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Series B underwent resection of the omentum, and Series C had the omentum 
placed on the serosal side of the ulcer. Series A to C were divided into groups, 
which were treated either with a neutral vehicle, indomethacin or bFGF. Seven 
days post ulcer induction, the animals were anaesthetised, the gastric blood flow 
was determined by laser Doppler flowmetry and the ulcer area was measured. 
Biopsy samples of the ulcer margin were taken for determination of capillary and 
myofibroblast density in the granulation tissue. Attachment of omentum 
significantly accelerated ulcer healing, whereas omentectomy delayed this 
process. Laser Doppler flowmetry revealed the decrease in the gastric mucosal 
blood flow at the ulcer margin to be 45% and at the ulcer bed to be 18% of the 
value recorded in the intact adjacent mucosa. Attachment of the omentum 
significantly increased the blood flow at the ulcer margin and increased the 
number of capillaries and myofibroblasts in the granulation tissue. Indomethacin 
significantly delayed -ulcer healing without affecting the blood flow in the ulcer 
area. Human recombinant bFGF did not prevent the induction of acute gastric 
lesions by 100% ethanol or acidified aspirin but enhanced the healing rate of 
acetic-acid induced gastric ulcers in rats. This enhanced healing was 
accompanied by an increase in the number of capillaries and myofibroblasts and 
in DNA synthesis in the surrounding granulation tissue. 
The higher systemic concentrations of bFGF in the patients with actively healing 
ulcers compared to those with non-healing ulcers, probably reflects the state of 
mucosal blood flow in the two groups. The healing ulcers had a higher mucosal 
blood flow and higher systemic concentrations of bFGF than the non-healing 
ulcers. The high systemic concentrations of bFGF reflect the level of activity at 
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the gastric ulcer. 
6.17 TRANSFORMING GROWTH FACTOR (TGF) 
TGF-p1 is also implicated in ulcer healing.37 Our own finding that TGF-p1 was 
elevated systemically in patients with healing ulcers in comparison to non-healing 
ulcers supports our current understanding of its role in promoting ulcer healing. 
TGF stimulates cell DNA synthesis, and epithelial cell migration and reduces the 
effect of ethanol on the gastric mucosa. Relatively higher systemic concentrations 
of TGF-p1 in patients with healing gastric ulcers compared to patients with non-
healing ulcers can be taken as evidence that TGF-p1 plays a role in healing 
gastric ulcers. 
6.18 EPIDERMAL GROWTH FACTOR (EGF) 
Konturek et al. assessed the rate of cell proliferation, gastric secretion and gene 
expression of mRNA for EGF and TGF during ulcer healing.27,38 They induced 
gastric ulcers in rats by serosal application of 100% acetic acid. In some of the 
rats, a gastric fistula was fashioned to enable assessment of acid secretion during 
ulcer healing. The animals were killed at different times after ulcer induction, and 
the ulcer area was determined. 
The mucosal sections with gastric ulcers were immuno-stained for Proliferating 
Cell Nuclear Antigen (PCNA) and for immuno-expression of EGF, TGF-a, and 
EGFR. The expression of mRNA EGF and mRNA TGF-a was also determined in 
the ulcer margin by Reverse Transcriptase (RT) Polymerase Chain Reaction 
(PCR) using specific primers. Two, four, six, and eight days after ulcer induction 
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the gastric ulcer area was gradually reduced from the initial size (day 0) by 47%, 
70%, 80%, and 87% respectively, and this was accompanied by an increase in 
PCNA with its maximum on day four. 
Konturek et al.27 showed that gastric, acid and pepsin secretion was significantly 
reduced two days post ulcer induction. Secretion had returned to normal by the 
eighth day. The expression of EGF, TGF, and EGFR was negligible initially, but 
increased significantly during the healing. Cell proliferation during ulcer healing 
seems to be mediated by an increased release of EGF and TGF. The expression 
of EGF and TGF and mRNA precedes the over-expression of these growth 
factors at the ulcer margin during ulcer healing. The over-expression of growth 
factors coincides with the inhibition of gastric secretion and increased blood flow 
at the ulcer margin. These factors all affect gastric secretion and blood flow in the 
course of ulcer healing. EGF is believed to inhibit gastric acid secretion by a 
separate mechanism to its mitogenic mechanism. 
Hui et al.11 5 has assessed the effect of oral EGF on gastric mucosal blood flow in 
rats following exposure to ulcerogenic stimulants. In this experiment blood flow, 
was measured by laser Doppler flowmetry. Male rats were anaesthetised and 
then subjected to a midline laparotomy. The stomach was exposed and the 
pylorus was ligated. The stomach was drawn up through an aperture in a 
plexiglass platform and opened. In effect this created an ex vivo stomach whilst 
leaving the vascular supply intact. Mucosal damage was induced by the 
application of pure ethanol. 
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Blood flow was determined at 0 and 15 minutes post exposure to ethanol. EGF or 
normal saline was applied to the mucosa after 30 minutes and blood flow was 
again determined at 45 minutes. Following the third blood flow measurement 
either normal saline or ethanol was applied to the mucosa. The authors showed 
that EGF at a dose greater than 6.25 J.lg decreased the size of the ethanol 
induced ulcer. Blood flow was Significantly higher in the mucosa exposed to EGF 
than the controls and the ulcer size was inversely related to the level of mucosal 
blood flow. The authors concluded that EGF increased mucosal blood flow and 
that this accounted for its early gastro-protective effect. 
Tarnawski et al. 116 demonstrated a 75-fold increase in the number of cells 
expressing EGFR in ulcerated rat gastric mucosa when compared to normals. 
This increase was specifically marked at the ulcer circumference. This indicated 
that the major target for EGF action was the ulcerated gastric mucosa. 
The above data indicates that EGF plays an important role in mucosal defence 
and mucosal healing. We could not demonstrate a significant difference in 
systemic levels of EGF in the healing ulcers in comparison to the non-healing 
ulcers. In light of the evidence this is surprising. It may be that at the early stage 
at which we collected the samples, EGF expression had not been suffiCiently 
stimulated. It may well be that an increase in EGF levels would only be detectable 
later in the healing process. 
It seems reasonable to ascribe the elevation in the systemic concentrations of 
these peptides to the increased level of activity and increased gastric mucosal 
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blood flow which accompanies mucosal healing. The next avenue of investigation 





There is a significant regional variation in the distribution of gastric mucosal blood 
flow in the human stomach, with blood flow in the antrum being lower than in the 
fundus. This reflects the lower functional state of the antrum when compared to 
the fundus and corresponds with described anatomical differences in the micro-
circulatory anatomy of the antrum and fundus. The lower blood flow in the antrum 
may contribute to the predilection of gastric ulceration in the distal stomach. The 
normal response of the gastric mucosa to injury is one of enhanced mucosal 
blood flow. We have demonstrated this in the setting of benign ulceration. The 
increase in gastric mucosal blood flow supports the high energy demanding 
process of re-epithelialisation. Failure of this response seems to inhibit mucosal 
healing. Low peri-ulcer blood flow implies that an ulcer will prove refractory to 
standard medical therapy. The elevated systemic concentrations of bFGF and 
TGF-~ 1 in patients with healing gastric ulcers in comparison to those in patients 
with non healing ulcers reflects the state of angiogenesis and active healing at the 
ulcer site. 80th arms of the study enhance our understanding of gastric ulceration 
and healing. The rationale behind the standard approach to gastric ulcer therapy, 
the reduction of acid and the eradication of H. pylori, have been shown to be 
based on the concept of gastric ulceration being due exclusively to noxious 
luminal substances. Understanding the importance of mucosal blood flow in 
gastric ulceration, alerts clinicians and investigators to other potential forms of 
therapy such as angiogenic promoting substances. Whilst the standard therapies 
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for gastric ulceration are highly effective, the novel therapeutic modalities 
currently under investigation may in the future complement them. This may result 
in improved quality of ulcer healing, and succeed in eliminating the problem of 
refractory and complicated gastric ulceration, which is still a cause of significant 
morbidity and even mortality. 
Our results have cl inical implications in predicting healing and non-healing of 
gastric ulceration. It would seem that non-healing of gastric ulcers can be 
predicted on the basis of reduced peri-ulcer mucosal blood flow, as measured by 
laser Doppler flowmetry and low systemic levels of bFGF. Further work is 
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MINUTE AVERAGES FOR FLOW IN NORMAL STOMACHS 
NORMAL STOMACHS NORMAL STOMACHS 
FlOW mllmin/100g FLOW ml/min/100g 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
19.7 109.4 35.3 88.7 89.9 80 
13.9 3.2 91.2 62.1 95.6 43.3 
59.7 75 42.6 86.4 87.3 61.1 
14.9 61 61 .8 61.3 86 52.6 
38.9 26.9 99 38.4 63 30 
58.8 50.9 122 80 58.6 109.7 
40.3 75.1 122 83.3 64.1 97.5 
37.8 26 47.9 88.7 41 52.2 
35.8 73.8 77.3 62.1 46.2 56.7 
16.8 49.7 142.3 86.4 51.5 74.4 
42.4 113.1 3.1 74.6 38.1 85.1 
86.2 111 .6 76.8 47 1.9 126.8 
31.1 81 110.9 76.6 46.5 101.8 
21.7 37.6 56~2 44.3 82.7 67 
45.4 131.1 56.7 64.4 93.1 100.2 
31.9 73.7 74.4 54.8 111.4 77.1 
39.3 84.1 62.4 53.9 60 91.6 
96.8 113.1 91 36.6 85.4 67.1 
57.8 91.6 42.9 14.9 97.8 78.6 
32.8 120.9 87.9 44.3 72.7 80 
13.9 30.3 25.1 35.1 97.5 19.7 
59.7 87.6 61.2 15.7 102.4 95.5 
14.9 23 66.1 57.1 81.8 37.8 
38.9 87.7 62.5 93.4 80.3 65.8 
86.7 51.5 51.9 53.2 67.9 51.4 
96 1.9 64.2 118.8 64.3 2.8 
55.2 60 117.2 80.7 85.6 108.9 
89.4 127 108.5 66.5 99 99 
60.4 54.7 99 29.7 77.8 68.2 
52.4 14.9 106.2 74.3 26.6 113.4 
80 64.3 79.6 88.3 97.2 92.2 
40.7 85.6 122 110.1 61 45.7 
81.2 75.3 111.6 60 50.2 45.2 
68 62.6 76 100.5 16.5 80.4 
49.4 90 34.4 80.4 111.9 
123.1 31.6 32 34.3 56.2 117.6 
92 
MINUTE AVERAGES FOR FLOW IN NORMAL STOMACHS contd 
NORMAL STOMACHS NORMAL STOMACHS 
FlOW ml/min/100g FLOW ml/min/100g 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
25 34.4 68.2 66.1 68.7 76.8 
29.1 68.5 92.2 68.1 88.5 111.6 
40.7 75 1.9 35.4 87.7 95.1 
104.2 63.2 76.8 85.1 51 .5 58.1 
61.8 83.5 88 62 93.1 79.9 
105.1 62.5 63.8 64.6 111.4 58.8 
34.7 75.7 63.5 74.9 60 63.8 
41 .3 113.8 69.5 66.5 73.6 25.1 
32.9 73.2 56.6 81.3 31.2 78 
68.8 73.6 92.1 91 98.6 99.4 
35 71.5 74.2 65 91.5 84.5 
50.4 38.1 17.6 97.9 71.5 72.1 
52 1.9 116.5 64.3 75.9 56.2 
52 46.5 38.1 74.3 71.7 72.1 
56.7 82.7 94.6 97.7 64.4 50.3 
111.8 44.1 3.1 61.8 83.5 88 
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MINUTE AVERAGES FOR VELOCITY IN NORMAL STOMACHS 
NORMAL STOMACHS NORMAL STOMACHS 
VELOCITY mm/sec VELOCITY mm/sec 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
2.4 5.5 5.0 6.6 5.6 6.5 
1.5 3.9 3.8 3.7 5.6 5.1 
2.0 4.5 3.6 4.6 8.2 4.5 
3.9 5.6 4.2 4.5 3.4 4.8 
1.7 4.4 4.3 1.9 5.6 1.8 
3,3 4.1 10.7 5.8 5.4 4.1 
3.4 4.5 10.7 6.1 5.3 5.3 
4.2 3.7 3.6 6.6 3.7 3.2 
4.7 6.0 7.0 3.7 4.7 3.8 
4.9 3.9 6.2 4.6 3.1 5.6 
2.5 6.2 0.5 2.9 3.3 6.1 
3.2 5.8 3.3 3.1 0.5 5.0 
6.0 4.7 6.0 7.0 2.7 3.4 
3.3 3.7 4.6 2.2 6.3 4.3 
1.9 5.6 3.8 4.5 7.8 5.0 
2.6 3.2 5.6 5.3 5.9 4.9 
4.0 5.0 4.7 4.7 4.0 4.1 
2.2 6.2 5.3 3.1 5.5 3.7 
5.1 5.6 3.2 1.2 4.1 4.2 
4.6 7.1 5.6 2.2 4.9 6.5 
1.8 2.7 2.9 3.0 4.4 3.2 
2.0 5.8 3.3 0.8 5.2 6.2 
3.9 3.0 3.8 3.2 4.7 6.1 
1.7 5.9 4.7 5.6 3.7 5.0 
3.3 3.1 3.1 3.9 2.8 4.1 
5.3 0.5 3.2 7.4 4.1 1.6 
6.8 4.0 6.9 4.1 7.6 4.8 
3.8 8.7 6.5 4.1 5.4 7.3 
5.6 4.4 4.3 1.9 5.8 4.2 
4.5 1.4 6.5 5.8 5.0 7.1 
3.1 4.1 6.4 4.5 5.0 3.7 
5.8 7.6 10.7 3.4 4.3 3.4 
4.1 4.1 5.8 5.6 4.0 3.5 
2.7 3.7 3.7 5.4 0.7 5.6 
2.6 6.0 2.8 4.4 1.7 5.3 
2.8 3.2 2.7 2.1 5.4 7.5 
4.2 3.6 4.2 3.5 4.7 3.3 
2.8 4.7 3.7 4.2 6.6 7.1 
2.4 4.5 1.0 3.7 5.9 7.7 
2.1 2.2 0.5 3.7 6.4 5.5 
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MINUTE AVERAGES FOR VELOCITY IN NORMAL STOMACHS CONTO 
NORMAL STOMACHS NORMAL STOMACHS 
VELOCITY mm/sec VELOCITY mm/sec 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
5.5 4.8 3.3 6.5 3.1 4.3 
5.1 4.5 4.7 3.2 3.3 3.6 
3.9 5.0 3.2 4.2 0.5 5.6 
5.0 5.2 4.7 4.2 2.7 3.6 
4.9 4.6 3.8 2.0 6.3 5.9 
4.8 4.7 4.1 4.2 7.8 4.8 
2.6 3.7 6.8 1.3 5.9 3.1 
3.8 5.3 4.5 3.6 4.0 5.4 
2.9 9.8 3.8 5.0 3.9 2.8 
2.9 4.2 3.2 4.6 4.8 6.2 
1.4 4.1 5.6 4.6 4.5 5.9 
5.2 4.5 6.2 6.0 3.4 3.4 
3.1 4.0 3.5 
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MINUTE AVERAGES FOR VOLUME IN NORMAL STOMACHS 
NORMAL STOMACHS NORMAL STOMACHS 
VOLUME BY% VOLUME BY% 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
7.5 11.3 5.7 4.9 9.0 5.7 
4.7 4.8 8.3 6.1 10.1 5.3 
2.9 7.2 4.5 12.5 6.3 11 .6 
8.9 3.9 11 .2 7.9 20.4 7.8 
2.3 3.5 23.1 6.1 4.0 7.8 
10.2 3.2 6.5 12.5 3.7 12.0 
16.9 7.2 6.5 12.6 5.1 9.3 
3.6 3.7 4.3 4.0 9.7 6.6 
5.4 3.9 4.6 14.5 6.5 8.2 
1 .1 8.4 12.1 3.4 6.8 5.0 
7.9 16.7 10.2 4.8 6.8 6.4 
1.6 8.5 5.3 7.3 0.7 4.8 
4.7 7.7 5.7 1.8 7.7 15.2 
5.8 3.8 5.2 14.5 4.9 9.1 
4.3 11.5 4.8 5.3 6.1 14.9 
5.3 15.3 12.3 3.4 9.3 6.8 
4.2 7.4 4.4 6.2 5.9 26.9 
4.0 16.7 8.2 8.1 13.5 9.6 
8.7 13.7 9.1 2.7 6.3 11.3 
3.8 13.6 7.4 11.8 9.6 5.7 
20.9 3.9 7.7 13.8 7.0 3.0 
6.8 10.6 11 .8 7.1 13.5 7.6 
23.0 2.8 7.6 10.4 7.5 1.8 
2.4 7.6 7.9 7.8 17.7 5.3 
8.5 6.8 23.1 6.5 10.3 3.8 
13.9 5.9 8.3 8.6 6.8 0.4 
12.6 8.2 8.2 4.2 5.1 4.2 
14.2 3.3 6.5 9.6 8.2 5.0 
2.9 2.9 8.5 5.6 5.2 8.1 
6.4 5.1 17.0 5.6 3.0 9.0 
17.4 8.7 4.2 10.5 12.1 4.5 
17.8 9.0 3.8 10.5 6.4 10.9 
11.2 7.7 8.1 15.5 4.3 7.8 
3.7 5.0 0.6 4.5 2.6 5.2 
4.8 3.5 0.5 2.3 0.1 19.9 
10.6 6.0 10.2 9.0 5.4 6.3 
4.0 7.2 5.7 8.0 5.0 10.2 
4.1 5.5 10.2 5.8 8.7 11.4 
4.8 9.0 5.7 9.9 7.6 7.6 
13.8 6.6 5.3 9.6 8.6 7.5 
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MINUTE AVERAGES FOR VOLUME IN NORMAL STOMACHS contd 
NORMAL STOMACHS NORMAL STOMACHS 
VOLUME BY % VOLUME BY% 
ANTRUM INCISURA FUNDUS ANTRUM INCISURA FUNDUS 
7.3 7.7 5.6 7.9 7.7 6.0 
4.2 5.4 7.7 1.6 4.9 6.0 
4.4 4.4 5.5 4.7 6.1 8.7 
4.5 6.9 4.8 11 .1 9.3 9.0 
5.3 8.8 9.8 2.5 5.9 4.1 
3.3 9.0 6.5 4.1 10.8 8.0 
9.5 5.4 10.2 6.2 2.2 3.7 
9.5 5.6 4.5 3.6 16.3 9.8 
6.5 12.1 8.0 2.9 9.0 8.0 
6.2 5.5 5.7 6.5 3.0 6.7 
7.4 6.8 4.6 8.0 5.0 10.3 
4.7 6.8 2.0 7.5 10.1 4.4 
1.1 6.1 11.1 
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GASTRIC ULCER MUCOSAL HAEMODYNAMIC MEASUREMENTS 
Unhealed Ulcers: Initial Unhealed Ulcers: 
Readings Follow-up Readings 
Flow Volume Velocity Flow Volume Velocity 
ml/m/100 By% mm/sec ml/m/100g By % mm/sec 
g 
Patient 1 45.7 11 .5 2.3 Patient 1 46.5 6.8 3.1 
Patient 2 20.9 4.8 1.1 Patient 2 41.0 6.9 2.3 
Patient 3 55.3 5.7 4.0 Patient 3 45.7 7.0 2.7 
Patient 4 81.0 6.9 5.6 Patient 4 35.4 7.5 2.1 
Patient 5 24.5 2.3 3.3 Patient 5 28.7 5.0 1.9 
Patient 6 44.0 6.0 2.0 Patient 6 38.5 3.6 3.9 
Average 45.2 6.2 3 Average 39.2 6.1 2.6 
SO 21.9 3 1.6 SO 6.7 1.4 
Healed Ulcers: Healed Ulcers: 
Initial Readings Follow -up readings 
Flow Volume Velocity Flow Volume Velocity 
ml/m/100g By % mm/sec mllm/100g By% mm/sec 
Patient 1 77.1 11.9 4.5 Patient 1 90.4 8.3 5.0 
Patient 2 93.7 11 .5 4.1 Patient 2 54.0 7.9 2.6 
Patient 3 53.7 7.0 3.7 Patient 3 58.6 7.2 2.7 
Patient 4 54.1 6.9 3.4 Patient 4 67.3 9.9 4.2 
Patient 5 84.6 6.3 5.8 Patient 5 86.7 8.4 4.9 
Patient 6 98.3 9.6 6.2 Patient 6 67.4 6.4 4.6 
Patient 7 77.0 16.0 3.0 Patient 7 73.9 6.5 5.1 
Patient 8 97.2 5.0 5.5 Patient 8 58.3 5.4 5.4 
Patient 9 60.1 9.0 3.5 Patient 9 55.4 6.4 3.8 
Patient 10 61 .3 12.6 2.8 Patient 10 85.4 4.8 5.9 
Average 75.7 9.6 4.2 Average 69.8 7.1 4.4 
SO 17.5 3.4 1.2 SO 13.7 1.5 1 
Healed Ulcers: Healed Ulcers: 
Initial readings only Follow-up Readings only 
Flow Volume Velocity Flow Volume Velocity 
ml/m/100g By % mm/sec ml/m/100g By % mm/sec 
Patient 1 61.2 7.7 3.8 Patient 1 59.4 5.9 3.2 
Patient 2 73.6 11.6 3.9 Patient 2 55.4 6.4 3.9 
Patient 3 70.7 4.5 Patient 3 61.2 4.0 4.3 
Patient 4 77.2 11 .9 4.5 Patient 4 113.4 4.3 5.3 
Patient 5 71 .2 8.1 4.1 
Patient 6 82.7 9.0 3.9 
Average 72.8 9.7 4.1 Average 72.4 5.2 4.2 SO 7.2 1.9 0.3 SO 27.4 1.2 0.8 
APPENDIX 2 
LASER DOPPLER 
THE PRINCIPLES AND THEORY OF LASER DOPPLER 
98 
Johann Christiaan Doppler in 1843 predicted that the pitch of sound of an 
approaching vehicle would be higher than that of a retreating vehicle . This effect 
was christened the Doppler shift in his honour. Any particles with a wave motion 
will exhibit this phenomenon. · Laser produces intense, concentrated and highly 
parallel beams of coherent light and allows for the detection of velocities that 
would be too small for detection by white light. Laser Doppler was initially applied 
t6 the field of fluid mechanics. 117,118 Realising, the usefulness of laser Doppler in 
measuring fluid flow involving particles suspended in a flow-stream, Stern et a/.62 
and Bonner and No_ssal63 applied it to the study of moving red cells in tissue. 
Laser Doppler can derive a value for blood flow, based on the detected reflected 
laser spectrum. 
A laser source generates a laser beam, which irradiates the mucosal surface 
under investigation. The tissue matrix surrounding the blood vessels is 
considered to be stationary and is a strong diffuser of light. This ensures that the 
moving red cells are illuminated by a spatially distributed source. The Doppler 
shift arises only from interactions between red cells and photons. The reflected 
light consists of Doppler shifted light and unshifted light. The randomisation of the 
incident light prior to interaction with the red cells and the effect of multiple 
scatterings with red cells, preclude an exact calculation of the shape of the 
Doppler spectrum. 
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The final spectrum is a superimposition of contributions from red cells moving 
with multiple velocities, and light which has been randomly scattered by stationary 
tissue. The wavelength of this spectrum is proportional to the velocity of the red 
cell and the cosine of the angle between the direction of the red cell motion and 
the scattering vector. For viscous flow in a fine network, this wavelength should 
scale in proportion to red cell flow. The amplitude of the Doppler signal will scale 
in proportion to the number of red cells in the flow field. As multiple collisions are 
expected, this is not a linear relationship. The major assumption made in applying 
laser Doppler to biological models is that red cell flow is laminar and that vascular 
geometry remains constant. It is generally accepted that these variations are not 
significant enough to affect the readings. 
The reflected photocurrent is passed through a low-pass filter, which is just wide 
enough to pass the entire Doppler spectrum. This signal consists of the Doppler 
signal and a noise component. Limiting the wavelength of the filter reduces the 
noise component without affecting the signal. Doppler flow (F) can be defined as 
the root-mean-square of the wave-length of the Doppler signal. 
F = -V jo/P(ro)dro 
In this equation, P(ro) is the power spectrum of the Doppler frequency. The 
Doppler signal is proportional to F2. 
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DERIVATION OF THE DOPPLER EQUATION 
The signal consists of a Dopper shifted component and a noise component. The 
noise component is proportional to the mean photocurrent and is white noise with 
an infinite wavelength and is independent of flow. 
Thus I = id+in 
I is the combined Doppler signal intensity. 
Id = Doppler signal 
In = noise component 
The spectral power of the combined signal is the sum of the Doppler signal and 
the noise. 
Thus 8(00) = p(oo)+al;oo<B 
In this equation, a is a constant, that depends on the gain of the phototube, I is 
the mean photocurrent and B is the wavelength of the filter. By differentiating the 
signal at this point, the power spectrum 8(00) , is multiplied by 002. The output of the 
root-mean-square detector, applied to this spectrum is the square root of the total 
integrated power in the spectrum. 
The fi~st term under the second square root sign is the flow parameter defined by 
F = ,j j oo2p(oo)dco, whilst the second term can be integrated directly to give sl , 
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where s is a constant dependent on the gain of the photodetector and its 
processing bandwidth. The final result is 
R = ~F2+sl 
This can be re-arranged to 
F = ~R-si 
Dividing the flow parameter by the mean photocurrent will normalize the unit 
intensity and give the final equation. 
F = ~(R2-sl)\1 
F = Flow 
R = output of the root-mean-square detector, which captures the combined signal. 
I = mean photocurrent. 
S is a constant, which depends on the gain of the photomultiplier. 
Division by I normalizes the flow parameter. This ensures that it is independent of 
the intensity of the laser and total reflectivity of the tissue. 
The frequency of the spectrum is proportional to the velocity of the scattering 
particles (red cells) and amplitude is proportional to the number of the scattering 
particles. 
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LASERFLO BLOOD PERFUSION MONITOR® 
The LASERFLO Blood Periusion Monitor® is unique in that it measures the three 
parameters of blood volume, blood velocity and blood flow. 11 9 Blood volume is 
derived from the mean number of Doppler scatterings per photon, which is 
derived from the proportion of detected photons that have undergone a Doppler 
shift. The instruments signal processor scales this result to provide an indication 
of blood volume in units of percent tissue haematocrit. Velocity is calculated by 
computing the first moment of the Doppler spectrum and then scaling this spectral 
moment to give an average velocity in mm/sec. The signal processor computes 
the product of the velocity and volume parameters to indicate local tissue blood 
flow in units of ml/minute/1 OOg. 
